☐ |
Preliminary Proxy Statement
|
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☒ |
Definitive Proxy Statement
|
☐ |
Definitive Additional Materials
|
☐ |
Soliciting Material under Rule 14a-12
|
☐ |
No fee required
|
☐ |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
(1)
|
Title of each class of securities to which transaction applies:
|
(2)
|
Aggregate number of securities to which transaction applies:
|
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is | |
calculated and state how it was determined):
|
(4)
|
Proposed maximum aggregate value of transaction:
|
(5)
|
Total fee paid:
|
☒ |
Fee paid previously with preliminary materials.
|
☐ |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous
filing by registration statement number, or the Form or Schedule and the date of its filing.
|
(1)
|
Amount Previously Paid: ______________________________________________________
|
(2)
|
Form, Schedule or Registration Statement No.:_____________________________________
|
(3)
|
Filing Party: ________________________________________________________________
|
(4)
|
Date Filed: _____________
|
1. |
Approval of the Agreement and Plan of Merger (the “Merger Agreement”), dated as of November 9, 2017, by and among the Company, B. Riley Financial, Inc., a Delaware corporation (“Parent”) and B. R. Acquisition Ltd., an Israeli corporation and an indirect wholly owned subsidiary of Parent (“Merger Sub”), and the terms of the merger contemplated thereby;
|
2. |
Approval, in accordance with the requirements of the Israeli Companies Law, 5759-1999, as currently amended (the “Companies Law”), of an amendment to the employment agreement and an amendment to the restricted stock agreement with the Company’s President and Chief Executive Officer, Don C. Bell III, related to the transactions contemplated by the Merger Agreement;
|
3. |
Approval, on a non-binding, advisory basis, of certain compensation that will be paid or may become payable to our named executive officers in connection with the merger; and
|
4. |
The transaction of such other business as may properly come before the Meeting and any adjournments or postponements thereof.
|
|
By Order of the Board of Directors,
MAGICJACK VOCALTEC LTD.
Don Carlos Bell III
President and Chief Executive Officer
February 8, 2018
|
3
|
|
The Transaction
|
3
|
The Meeting
|
6
|
9
|
|
Parties to the Transaction
|
9
|
The Meeting
|
10
|
Recommendation of the Board
|
10
|
The Agreement and Plan of Merger
|
11
|
Appraisal Rights
|
11
|
Opinion of BofA Merrill Lynch
|
11
|
Treatment of the Company’s Stock Options and Restricted Stock in the Transaction
|
11
|
Interests of Our Directors and Executive Officers in the Transaction
|
12
|
Conditions to Completion of the Transaction
|
12
|
No Solicitation
|
13
|
Termination of the Merger Agreement
|
14
|
Termination Fees
|
15
|
Financing of the Transaction
|
15
|
Delisting and Deregistration of the Company’s Ordinary Shares
|
15
|
Expenses
|
15
|
Material U.S. Federal Income Tax Considerations of the Transaction
|
16
|
Regulatory Matters
|
16
|
17
|
|
18
|
|
Date, Time and Place of the Meeting
|
18
|
Purpose of the Meeting
|
18
|
Persons Entitled to Vote; Quorum; Vote Required
|
18
|
Proxies and Voting Procedures
|
18
|
Mailing of Proxy Statement
|
19
|
Registered Office
|
19
|
Abstentions and Broker Non-Votes
|
19
|
Adjournments
|
19
|
Cost of Proxy Distribution and Solicitation
|
20
|
21
|
|
22
|
|
Background of the Transaction
|
22
|
Recommendation of the Board; Reasons for the Transaction
|
38
|
Opinion of BofA Merrill Lynch
|
42
|
Certain magicJack Unaudited Prospective Financial Information
|
50
|
Financing of the Transaction
|
52
|
Interests of Our Directors and Executive Officers in the Transaction
|
52
|
Delisting and Deregistration of the Company’s Ordinary Shares
|
59
|
Regulatory Approvals Required for the Transaction
|
59
|
Material U.S. Federal Income Tax Considerations of the Transaction
|
60
|
U.S. Federal Income Tax Considerations to U.S. Holders of the Disposition of Company Ordinary Shares
|
61
|
Certain Israeli Tax Considerations to U.S. Holders of the Disposition of Company Ordinary Shares
|
62
|
Tax Considerations in Other Jurisdictions
|
62
|
63
|
|
Explanatory Note Regarding the Merger Agreement
|
63
|
The Merger; Articles of Association; Memorandum of Association; Directors and Officers
|
63
|
Effective Time
|
63
|
Merger Consideration
|
64
|
Treatment of Company Equity Awards
|
64
|
Payment Procedures
|
64
|
Representations and Warranties
|
65
|
Covenants Relating to Conduct of Business Pending the Closing
|
66
|
Non-Solicitation; Acquisition Proposals; Change in Recommendations
|
68
|
Shareholder Meeting
|
70
|
Indemnification and Insurance
|
70
|
Efforts to Obtain Regulatory Approvals and Tax Ruling
|
71
|
Merger Proposal; Certificate of Merger
|
71
|
Financing Cooperation
|
72
|
Other Covenants
|
72
|
Conditions to Completion of the Merger
|
73
|
Termination of the Merger Agreement
|
74
|
Effect of Termination
|
75
|
Transaction Expenses; Termination Fees
|
75
|
Amendment
|
76
|
Binding Effect; Assignment; Guaranty of Obligations
|
76
|
Third Party Beneficiaries
|
77
|
Specific Performance
|
77
|
Governing Law
|
77
|
78
|
|
79
|
|
Compensation Discussion and Analysis
|
79
|
Compensation Committee Report
|
86
|
2017 Summary Compensation Table
|
87
|
2017 Pay Ratio Disclosure
|
88
|
2017 Grants of Plan-Based Awards
|
88
|
2017 Outstanding Equity Awards and Stock Vesting
|
89
|
Pension Benefits and Nonqualified Deferred Compensation
|
90
|
Employment Agreements and Potential Payments Upon Termination or Change of Control for Named Executive Officers
|
90
|
Compensation Committee Interlocks and Insider Participants
|
101
|
2017 Director Compensation
|
102
|
104
|
|
106
|
|
107
|
|
109
|
|
110
|
|
110
|
|
110
|
|
111
|
|
Other Business
|
111
|
ANNEX A - Agreement and Plan of Merger | A - 1 |
ANNEX B - Opinion of Merrill Lynch, Pierce, Fenner & Smith Incorporated | B -1 |
1. |
Approval of the Agreement and Plan of Merger (the “Merger Agreement”), dated as of November 9, 2017, by and among the Company, B. Riley Financial, Inc., a Delaware corporation (“Parent”) and B. R. Acquisition Ltd., an Israeli corporation and an indirect wholly owned subsidiary of Parent (“Merger Sub”), and the terms of the merger contemplated thereby (the “Merger Proposal”);
|
2. |
Approval, in accordance with the requirements of the Israeli Companies Law, 5759-1999, as currently amended (the “Companies Law”), of an amendment to the employment agreement and an amendment to the restricted stock agreement with the Company’s President and Chief Executive Officer, Don C. Bell III, related to the transactions contemplated by the Merger Agreement (the “CEO Compensation Proposal”);
|
3. |
Approval, on a non-binding, advisory basis, of certain compensation that will be paid or may become payable to our named executive officers in connection with the merger (the “Golden Parachute Payments Proposal”); and
|
4. |
The transaction of such other business as may properly come before the Meeting.
|
Q: |
What is the Transaction?
|
A: |
The Company, Parent and Merger Sub have entered into the Merger Agreement pursuant to which Parent proposes to acquire all of the outstanding ordinary shares of the Company (other than those held by Parent, Merger Sub and their subsidiaries) as a result of the merger of Merger Sub with and into the Company (the “Merger”) for $8.71 per share in cash, without interest, which we refer to as the “Per Share Merger Consideration.” The transactions contemplated by the Merger Agreement, including the Merger, are referred to as the “Transaction” for purposes of this proxy statement. The Merger Agreement is attached to this proxy statement as Annex A. We encourage you to review the Merger Agreement in its entirety.
|
Q: |
What will the Company’s shareholders receive when the Transaction occurs?
|
A: |
For every Company ordinary share held at the effective time of the Merger, the Company’s shareholders (other than Parent, Merger Sub and their subsidiaries) will be entitled to receive $8.71 in cash, without interest, less any applicable withholding taxes.
|
Q: |
How does the purchase price compare to the market price of the Company’s ordinary shares?
|
A: |
The purchase price of $8.71 per share to be received by the Company’s shareholders represents a premium of approximately (i) 18.5% over the closing price of the Company’s ordinary shares on the NASDAQ Global Select Market on March 14, 2017, the last completed trading day prior to the date that the Company announced that it had received unsolicited indications of interest and would be considering its strategic alternatives, (ii) 23.6% over the 90-day average closing price of the Company’s ordinary shares for the period ended November 7, 2017, and (iii) 54.2% over the closing price of the Company’s ordinary shares on the NASDAQ Global Select Market on November 8, 2017, the last completed trading day prior to the Company’s announcement that it entered into the Merger Agreement.
|
Q: |
When do you expect the Transaction to be completed?
|
A: |
The Transaction is subject to various closing conditions, including Company shareholder approval and regulatory approvals. We hope to complete the Transaction in the first half of 2018.
|
Q: |
What are the other Proposals and how do they relate to the Transaction?
|
A: |
Proposal 2 relates to approving amendments to the employment agreement and the restricted stock agreement of the Company’s Chief Executive Officer, Don C. Bell III, (i) to allow Mr. Bell to receive certain compensation upon the consummation of the Merger and (ii) to postpone the vesting of the restricted share awards that were previously granted to Mr. Bell and cause such awards to be forfeited upon the consummation of the Merger. These arrangements were approved by our Compensation Committee and our Board on November 7, 2017 contingent upon approval and execution of the Merger Agreement. These arrangements are described in more detail in “The Transaction—Interests of Our Directors and Executive Officers in the Transaction—Golden Parachute Compensation—Don C. Bell III Executive Employment Agreement” beginning on page 54 , and under Proposal 2 below.
|
Q: |
How does the Board recommend that I vote on the Proposals?
|
A: |
The Board unanimously determined that it is in the best interest of the Company that the Company enter into the Merger Agreement and consummate the Transaction, and unanimously recommends that you vote “FOR” the Merger Proposal. You should read the section entitled “The Transaction—Recommendation of the Board; Reasons for the Transaction” beginning on page 38.
|
Q: |
What effects will the Transaction have on the Company?
|
A: |
As a result of the Transaction, the Company will cease to be a standalone public company and will be an indirect wholly owned subsidiary of Parent. The Company’s ordinary shares will no longer be publicly traded and will be delisted from the NASDAQ Global Select Market. In addition, the Company’s ordinary shares will be deregistered under the United States Securities Exchange Act of 1934, as amended (the “Exchange Act”), upon application to the SEC, and we will no longer file periodic reports with the SEC.
|
Q: |
What will happen in the Transaction to the Company’s stock option awards?
|
A: |
With the exception of the options issued to Don C. Bell III, the Company’s Chief Executive Officer, each Company stock option, whether or not vested or exercisable, that is unexpired, unexercised and outstanding immediately prior to the effective time of the Merger will vest and terminate in its entirety at the effective time. The holder of each such stock option will be entitled to receive an amount in cash equal to the product of: (i) the excess of (x) $8.71 over (y) the per share exercise price of such option, multiplied by (ii) the number of ordinary shares underlying each such option, which amount will be paid less any applicable withholding taxes. To the extent any unexpired and outstanding Company stock option has an exercise price that is equal to or greater than the purchase price of $8.71, such option will be cancelled for no consideration. The options issued to Mr. Bell will be cancelled for no consideration effective as of the effective time of the Merger.
|
Q: |
What will happen in the Transaction to the Company’s restricted share awards?
|
A: |
Company restricted share awards outstanding immediately prior to the effective time of the Merger will become vested as a result of the Merger, only if and to the extent provided by the terms of the award or applicable Company equity plan, and any portion of the award that does not become so vested will be forfeited. Each vested restricted share will be cancelled and converted into the right to receive a cash payment with respect thereto equal to $8.71 per share, less any applicable withholding taxes.
|
Q: |
Do any of the Company’s directors or executive officers have interests in the Transaction that may differ from those of the Company’s shareholders?
|
A: |
Yes, some of our directors and executive officers may have interests in the Transaction that are different from, or in addition to, the interests of the Company’s shareholders generally. The Board was aware of and considered these interests, among other matters, in reaching its decision to approve entry into the Merger Agreement and the consummation of the Merger. See “The Transaction—Interests of Our Directors and Executive Officers in the Transaction” beginning on page 52 for a description of such interests.
|
Q: |
What are the material U.S. federal income tax considerations of the Transaction to the Company’s shareholders?
|
A: |
The receipt of cash for Company ordinary shares by U.S. holders (as defined in “The Transaction—Material U.S. Federal Income Tax Considerations of the Transaction”) pursuant to the Transaction will be a taxable transaction for U.S. federal income tax purposes. In general, for U.S. federal income tax purposes, a U.S. holder of the Company’s ordinary shares will recognize gain or loss in an amount equal to the difference, if any, between (i) the amount of cash received in the Transaction and (ii) the U.S. holder’s adjusted tax basis in the shares. A non-U.S. holder (as defined in “The Transaction—Material U.S. Federal Income Tax Considerations of the Transaction”) of the Company’s ordinary shares generally will not be required to pay U.S. federal income tax on the receipt of cash in exchange for the Company’s ordinary shares in the Transaction unless such non-U.S. holder has certain connections to the United States. See “The Transaction—Material U.S. Federal Income Tax Considerations of the Transaction” beginning on page 60 for a more detailed discussion of the U.S. federal income tax treatment of the Transaction.
|
Q: |
How will I be paid the Per Share Merger Consideration for my shares?
|
A: |
On or prior to the closing date of the Merger, Parent or Merger Sub will deposit with a paying agent cash in an amount equal to the aggregate Per Share Merger Consideration payable to all shareholders (other than Parent, Merger Sub and their subsidiaries) as of the closing date of the Merger. The paying agent will provide instructions to our shareholders on how to surrender shares for payment of the Per Share Merger Consideration.
|
Q: |
Should I send in my share certificates or other proof of ownership now?
|
A: |
No. The paying agent will provide a letter of transmittal to our shareholders after the effective time of the Merger. The letter will describe how you can surrender your share certificates for the Per Share Merger Consideration. If your shares are held in “street name” by your bank, brokerage firm or other nominee, you will receive instructions from them as to how to surrender your “street name” shares in exchange for the Per Share Merger Consideration. Please do not send in your stock certificates now.
|
Q: |
Am I entitled to appraisal rights in connection with the Transaction?
|
A: |
No. There are no appraisal or similar rights of dissenters under Israeli law, whether you vote for or against the Merger Proposal.
|
Q: |
What happens if I sell my ordinary shares before the Meeting?
|
A: |
The record date for shareholders entitled to vote at the Meeting is earlier than the date of the Meeting and the expected closing date of the Merger. If you transfer your ordinary shares of the Company after the record date but before the Meeting, you will, unless special arrangements are made, retain your right to vote at the Meeting but will transfer the right to receive the Per Share Merger Consideration to the person to whom you transfer your shares.
|
Q: |
What happens if the Merger Proposal is not approved by the Company’s shareholders or if the Transaction is not completed for any other reason?
|
A: |
If the Merger Proposal is not approved by our shareholders or if the Transaction is not completed for any other reason, our shareholders will not receive any payment for their shares in connection with the Transaction. Instead, we will remain a standalone public company, the Company’s ordinary shares will continue to be listed and traded on the NASDAQ Global Select Market and registered under the Exchange Act, and we will continue to file periodic reports with the SEC.
|
Q: |
When and where is the Meeting?
|
A: |
The Meeting will be held at 10:00 a.m., local time, on March 19, 2018 at the offices of Bryan Cave LLP, 1290 Avenue of the Americas, 35th Floor, New York, NY 10104.
|
Q: |
What quorum and shareholder vote are required to approve the Proposals?
|
A: |
A quorum is required for the transaction of business at the Meeting. Two or more shareholders, present in person or by proxy and holding shares conferring in the aggregate not less than one-third of the voting power of the Company as of the record date of February 7, 2018 will constitute a quorum. Each Company share is entitled to one vote on each Proposal.
|
· |
the majority voted in favor includes a majority of the shares held by non-controlling shareholders who do not have a personal interest in the approval of Proposal 2 that are voted at the Meeting, excluding abstentions; or
|
· |
the total number of shares held by non-controlling, disinterested shareholders (as described in the previous bullet-point) that are voted against approval of Proposal 2 does not exceed two percent of the aggregate voting rights in the Company.
|
Q: |
How can I vote?
|
A: |
Shareholders of record at the record date of February 7, 2018 may vote by personally attending the Meeting or attending by proxy, by completing and returning a proxy card. If you hold your shares in “street name” through a bank, broker or other nominee, you will be able to exercise your vote through such organization by completing a voting instruction form in accordance with the procedures issued by such organization. “Street name” holders may be able to submit their voting instructions to their bank, broker or other nominee by telephone or through the Internet.
|
Q: |
What do I do if I receive more than one proxy card or set of voting instructions?
|
A: |
If you hold shares in “street name”, directly as a record holder or otherwise, you may receive more than one proxy card and/or set of voting instructions relating to the Meeting. If more than one proxy card is received, you should vote and return each proxy card separately in accordance with the applicable voting instructions and this proxy statement in order to ensure that all of your shares are voted.
|
Q: |
If my ordinary shares are held in “street name” by my bank, broker or other nominee, will they vote my shares for me?
|
A: |
Your broker, bank or nominee will not be able to vote any of your shares without instructions from you. The vote on each of the Proposals is considered a “non-routine” matter, and your bank, broker or other nominee is not permitted to exercise discretion to vote your ordinary shares. If you hold your ordinary shares in “street name,” you should follow the procedures provided by your bank, broker or other nominee regarding how to instruct them to vote your shares. Typically, you would submit your voting instructions by mail, by telephone or through the Internet in accordance with the procedures provided by your bank, broker or other nominee. Without instructions, your shares will not be voted.
|
Q: |
How are votes counted?
|
A: |
You may vote FOR or AGAINST each of the Proposals, or you may abstain from voting on each of the Proposals. Abstentions will not be counted as votes cast or shares voting on the proposal, but will count for the purposes of determining whether a quorum is present. Pursuant to Israeli law, broker non-votes will not be counted as present for the purpose of determining the presence or absence of a quorum for the transaction of business and, therefore, will not be counted for the purpose of determining whether a quorum is present or approval is obtained with respect to any Proposal.
|
Q: |
Can I revoke or change my vote?
|
A: |
Yes. Shareholders have the right to revoke a proxy at any time prior to voting at the Meeting by (i) submitting a subsequently dated proxy, which, if not delivered in person at the Meeting, must be received by us no later than two hours before the appointed time of the Meeting or (ii) attending the Meeting and voting in person, provided that you are a registered shareholder. If you hold ordinary shares in “street name” through a broker, bank or other nominee, you should follow the procedures provided by such organization to revoke or change your vote.
|
Q: |
What happens if I do not submit a proxy card or otherwise vote?
|
A: |
Your shares will not be voted on any of the Proposals and will not be counted as present at the Meeting. Failure to submit a proxy card or otherwise vote could make it more difficult for us to achieve the requisite thresholds we need for approval of the Proposals. Therefore, we urge all Company shareholders to vote, and we request that you return the proxy card as soon as possible.
|
Q: |
What do Company shareholders need to do now?
|
A: |
Carefully read and consider the information contained in and incorporated by reference into this proxy statement, including its annexes. In order for Company ordinary shares to be represented at the Meeting, shareholders can (i) indicate on the enclosed proxy card how they would like to vote and return the proxy card in the accompanying pre-addressed postage paid envelope or (ii) attend the Meeting in person. If your shares are held in “street name” through your broker, bank or other nominee, please follow the procedures provided by such organization regarding how to instruct them to vote your shares.
|
Q: |
Who can answer questions?
|
A: |
Company shareholders with questions about the Proposals or the Meeting, or who desire additional copies of this proxy statement or additional proxy cards should contact our proxy solicitor:
|
· |
the approval of the Merger Agreement and the terms of the Merger by the Company’s shareholders;
|
· |
the absence of any governmental orders or proceedings that make the Transaction illegal or otherwise prohibit the consummation of the Transaction;
|
· |
the passing of at least 50 days after the required filing of a merger proposal with the Registrar of Companies of the State of Israel (the “Companies Registrar”) and at least 30 days after approval of the Merger Agreement and the terms of the Merger by the shareholders of each the Company and Merger Sub;
|
· |
the expiration or termination of the applicable waiting period (and any extension thereof) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, which we refer to as the “HSR Act;” and
|
· |
all required approvals of the United States Federal Communications Commission or any successor thereof (the “FCC”) and similar state regulatory approvals and filings have been made or obtained.
|
· |
the representations and warranties of Parent and Merger Sub contained in the Merger Agreement shall be true and correct (without giving effect to materiality qualifications or limitations) on and as of the date of the Merger Agreement and as of the closing date (except to the extent such representations and warranties relate to a specified date, in which case as of such specified date), except for failures that, individually or in the aggregate, would not reasonably be expected to prevent, materially delay or materially impair the consummation of the Transaction or the performance by Parent or Merger Sub of their obligations under the Merger Agreement;
|
· |
Parent and Merger Sub shall each have performed or complied in all material respects with all agreements and covenants required by the Merger Agreement to be performed or complied with by it on or prior to the effective date of the Merger;
|
· |
the Company shall have received at the closing of the Merger a certificate signed by an executive officer of B. Riley and Merger Sub certifying as to the satisfaction of the conditions set forth in the two immediately preceding bullets;
|
· |
B. Riley shall have transferred the aggregate amount of consideration due with respect to the Company shares (other than excluded shares), stock options and restricted shares in accordance with the terms of the Merger Agreement; and
|
· |
B. Riley Principal Investments shall have executed an undertaking in customary form in favor of the Israeli Innovation Authority (“IIA”) to comply with the provisions of the Israeli Encouragement of Research, Development and Technological Innovation in the Industry Law 5744-1984 (the “R&D Law”).
|
· |
the representations and warranties of the Company contained in the Merger Agreement, as of the date of the Merger Agreement and as of the closing date (except to the extent such representations and warranties relate to an earlier date, in which case as of such earlier date), with respect to (i) corporate authority, capitalization and no material adverse effect shall be true and correct in all respects (except in the case of capitalization, for de minimis inaccuracies), (ii) standing and corporate power, takeover laws, the financial advisor opinion and the absence of brokers shall be true and correct in all material respects, and (iii) all other representations of the Company shall be true and correct (without giving effect to materiality qualifications or limitations), except, with respect to (iii), to the extent any failures would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect (as defined in the Merger Agreement);
|
· |
the Company shall have performed or complied in all material respects with all agreements and covenants required by the Merger Agreement to be performed or complied with by it at or prior to the effective date of the Merger;
|
· |
B. Riley shall have received at the closing of the Merger a certificate signed by an executive officer of the Company certifying as to the satisfaction of the conditions set forth in the two immediately preceding bullets;
|
· |
the approval required to be obtained from the IIA of the written notice to the IIA regarding the change in ownership of the Company effected as a result of the Merger, required to be submitted to the IIA in connection with the Merger in accordance with the R&D Law, shall have been granted;
|
· |
the Company or its subsidiaries shall have filed specified tax returns; and
|
· |
all required governmental authorizations, approvals and clearances and all expirations or terminations of waiting periods (including any extensions thereof) shall have been obtained without the imposition of a condition that is not contingent on the consummation of the Merger or that would reasonably be expected to have a material adverse effect on the business, results of operations or financial condition of the Company and its subsidiaries (taken as a whole) or Parent and its subsidiaries (taken as a whole, after giving effect to the Merger) measured on a scale relative to the Company and its subsidiaries (see “The Agreement and Plan of Merger—Efforts to Obtain Regulatory Approvals and Tax Ruling” beginning on page 71).
|
· |
solicit, initiate, knowingly encourage or knowingly facilitate the making or submission of any acquisition proposal (as defined in the Merger Agreement and summarized in “The Agreement and Plan of Merger—Non-Solicitation; Acquisition Proposals; Change in Recommendations” beginning on page 68);
|
· |
enter into, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any person any information in connection with, or enter into any agreement with respect to any acquisition proposal or any inquiry, proposal or offer, or take any other action to facilitate inquiries or the making of any proposal that constitutes or could reasonably be expected to lead to, any acquisition proposal;
|
· |
terminate, amend, modify or waive any provision of any confidentiality, “standstill” or similar agreement under which it has any rights, or fail to enforce in all material respects each such agreement with respect to an acquisition proposal;
|
· |
approve, endorse or recommend any acquisition proposal;
|
· |
enter into any agreement (including any letter of intent, acquisition agreement or similar agreement) relating to any acquisition proposal, other than a confidentiality agreement in connection with a potential superior proposal (as defined in the Merger Agreement and summarized in “The Agreement and Plan of Merger—Non-Solicitation; Acquisition Proposals; Change in Recommendations” beginning on page 68); or
|
· |
propose publicly or agree to any of the foregoing with respect to an acquisition proposal.
|
· |
the closing of the Transaction does not occur on or before August 9, 2018 (the “End Date”), except that (i) under certain circumstances, the End Date may be automatically extended to November 9, 2018; and (ii) a party may not terminate under this provision if such party’s breach or failure to perform or comply with any obligation under the Merger Agreement resulted in or was a proximate cause of the failure of the Transaction to be completed on or before the End Date;
|
· |
a governmental entity of competent jurisdiction shall have enacted or issued any order or law permanently enjoining, restraining, prohibiting or making illegal the consummation of the Transaction, and is final and nonappealable; provided that a party may not terminate under this provision if such party’s breach or failure to perform or comply with any obligation under the Merger Agreement resulted in or was a proximate cause of such government action, or if such party seeking to terminate the Merger Agreement has not complied with its obligations under the Merger Agreement to have any such government action removed; or
|
· |
the Company’s shareholders do not approve the Merger Agreement and terms of the Merger at the Meeting.
|
· |
if the Company breaches any of its covenants, representations or warranties in a manner that causes the closing conditions regarding its representations, warranties and covenants not to be satisfied and such violation or breach has not been expressly waived in writing by Parent, Parent has provided written notice of its intent to terminate to the Company and such violation or breach may not be cured by the End Date or, to the extent curable, has not been cured within the earlier of a 30-day cure period or three business days prior to the End Date, provided that neither Parent nor Merger Sub has materially breached the Merger Agreement; or
|
· |
in the event that (a) the Board has effected a Company adverse recommendation change (as defined in the Merger Agreement and summarized in “The Transaction—Recommendation of the Board; Reasons for the Transaction” beginning on page 38 of this proxy statement) or (b) at any time following receipt of an acquisition proposal, the Board fails to reaffirm its approval or recommendation of the Merger Proposal within five business days of receipt of written request to do so from Parent.
|
· |
Parent or Merger Sub breaches any of their respective covenants, representations or warranties in a manner that causes the closing conditions regarding such representations, warranties and covenants not to be satisfied and such violation or breach has not been expressly waived in writing by the Company, the Company has provided written notice of its intent to terminate to Parent and such violation or breach may not be cured by the End Date or, to the extent curable, has not been cured within the earlier of a 30-day cure period or three business days prior to the End Date, provided that the Company has not materially breached the Merger Agreement; or
|
· |
prior to obtaining approval of the Merger Proposal, in response to a superior proposal that was not solicited in material violation of the Merger Agreement, the Company enters into a definitive agreement with respect to an acquisition proposal that the Company has concluded constitutes a superior proposal, provided that the Company pays to Parent the termination fee.
|
· |
the risk that the Transaction may not be completed in a timely manner or at all, which may adversely affect the Company’s business and the price of its ordinary shares;
|
· |
the failure to obtain the Company shareholder approval of the Merger Proposal;
|
· |
the possibility that the closing conditions to the Transaction may not be satisfied or waived, including that a governmental entity may prohibit, delay or refuse to grant a necessary regulatory approval;
|
· |
the potential for regulatory authorities to require divestitures in connection with the proposed Transaction;
|
· |
the occurrence of any event that could give rise to termination of the Merger Agreement;
|
· |
the risk of shareholder litigation that may be instituted in connection with the contemplated Transaction;
|
· |
risks related to the diversion of management’s attention from the Company’s ongoing business operations;
|
· |
the effect of the announcement of the Transaction on the Company’s ability to retain and hire key personnel and maintain relationships with customers, suppliers and other third parties; and
|
· |
difficult global economic and capital markets conditions.
|
· |
a premium of approximately 54.2% over the closing price per share of Company shares on the NASDAQ Global Select Market on November 8, 2017, the trading day before the execution of the Merger Agreement;
|
· |
a premium of approximately 18.5% over the closing price per share of Company shares on the NASDAQ Global Select Market on March 14, 2017, the trading day before the Company announced it was exploring strategic alternatives; and
|
· |
a premium of approximately 23.6% over the 90-day average closing price of the Company’s ordinary shares for the period ended November 7, 2017.
|
· |
the Company’s ability to successfully distribute and commercialize new products;
|
· |
the Company’s ability to grow organically and through acquisitions;
|
· |
the competitive nature of the Company’s industry and target markets; and
|
· |
general risks and market conditions that could reduce the market price of the Company’s shares.
|
· |
Ability to Respond to Certain Unsolicited Acquisition Proposals— the Merger Agreement permits the Board to engage in negotiations or discussions with any third-party that has made an unsolicited bona fide written acquisition proposal that the Board, acting upon the recommendation of the Committee, determines in good faith (after consultation with its financial advisor and outside legal counsel) constitutes or would reasonably be expected to result in a superior proposal if such action is reasonably likely to be necessary in order for the directors to comply with their fiduciary duties under applicable Law (assuming the laws of Israel follow those of Delaware with respect to these matters).
|
· |
Change of Recommendation— either in the event that the Company receives a superior proposal or in the event of an intervening event (as defined in the Merger Agreement and summarized in “The Agreement and Plan of Merger—Non-Solicitation; Acquisition Proposals; Change in Recommendations”), the Board has the right, prior to obtaining shareholder approval of the Merger Proposal, to withhold, withdraw, modify or qualify, in any manner adverse to Parent, its recommendation to its shareholders of the Merger Proposal if the Board, acting upon the recommendation of the Committee, concludes in good faith, after consultation with its financial advisor and outside legal counsel that such action is reasonably likely to be necessary in order for the directors to comply with their fiduciary duties under applicable Law (assuming the laws of Israel follow those of Delaware with respect to these matters); provided that the Board may not make such a Company adverse recommendation change unless (i) the Company notifies Parent in writing at least four business days before the Company adverse recommendation change of its intention to take such action, and provides Parent with certain information relating to the superior proposal or intervening event, (ii) the Company negotiates in good faith with Parent concerning any revisions to the terms of the Merger Agreement that Parent may propose in response to such superior proposal or intervening event, and (iii) the Board determines that, in the case of a superior proposal, such acquisition proposal continues to constitute a superior proposal, and in the case of the intervening event, such intervening event continues to materially adversely affect the advisability of the Merger Agreement and the Merger to the Company from a financial point of view, in each case after giving due consideration to any changes proposed to be made to the Merger Agreement by Parent in writing.
|
· |
Fiduciary Termination Right— the Board may terminate the Merger Agreement to accept a superior proposal (that was not solicited in violation of the Merger Agreement) if (i) the Company has materially complied with requirements set forth in the previous bullet and (ii) in connection with such termination, the Company pays to Parent a termination fee of $5,738,297.
|
· |
Conditions to Consummation of the Merger; Likelihood of Closing— the fact that Parent’s obligations to close the Merger are subject to a limited number of conditions and the Board’s belief that the Merger is reasonably likely to be consummated.
|
· |
No Financing Condition—the Transaction is not subject to a financing condition.
|
· |
Remedies—remedies include specific performance and uncapped damages resulting from any willful and material breach of the Merger Agreement.
|
· |
reviewed certain publicly available business and financial information relating to the Company;
|
· |
reviewed certain internal financial and operating information with respect to the business, operations and prospects of the Company furnished to or discussed with BofA Merrill Lynch by the Company’s management, including certain financial forecasts relating to the Company (including financial forecasts relating to the magicJack Spark initiative) prepared by the Company’s management, referred to as the “magicJack forecasts”, and discussed with the Company’s management its assessment of the probability of success of the magicJack Spark initiative reflected in the magicJack forecasts;
|
· |
discussed the past and current business, operations, financial condition and prospects of the Company with members of senior management of the Company;
|
· |
reviewed the trading history for the Company ordinary shares and a comparison of that trading history with the trading histories of other companies BofA Merrill Lynch deemed relevant;
|
· |
compared certain financial and stock market information of the Company with similar information of other companies BofA Merrill Lynch deemed relevant;
|
· |
compared certain financial terms of the Merger to financial terms, to the extent publicly available, of other transactions BofA Merrill Lynch deemed relevant;
|
· |
considered the fact that the Company publicly announced that it would explore its strategic alternatives and the results of BofA Merrill Lynch’s efforts on behalf of the Company to solicit, at the direction of the Company, indications of interest and definitive proposals from third parties with respect to a possible acquisition of the Company;
|
· |
reviewed a draft, dated November 8, 2017, of the Merger Agreement, referred to as the “draft merger agreement”; and
|
· |
performed such other analyses and studies and considered such other information and factors as BofA Merrill Lynch deemed appropriate.
|
· |
its implied growth rate represented by its estimated revenue for calendar year 2017 compared to its estimated revenue for calendar year 2018; and
|
· |
its enterprise value, calculated as its equity value based on its closing share price on November 3, 2017, plus its total debt, preferred equity and minority interests less its cash and cash equivalents, short-term investments and long-term investments, in each case based on the company’s most recent public filings, as a multiple of its estimated revenue for each of calendar years 2017 and 2018.
|
Company
|
CY 2017E EV/Revenue
|
CY 2018E EV/Revenue
|
2017-2018
Growth Rate |
|||
8x8, Inc.
|
4.27x
|
3.62x
|
17.8%
|
|||
Five9, Inc.
|
7.84x
|
6.67x
|
17.6%
|
|||
LivePerson, Inc.
|
3.16x
|
2.95x
|
7.3%
|
|||
Ooma, Inc.
|
1.39x
|
1.29x
|
8.3%
|
|||
RingCentral, Inc.
|
7.26x
|
5.87x
|
23.7%
|
|||
Vonage Holdings Corp.
|
2.29x
|
2.23x
|
2.3%
|
|||
Mean
|
4.37x
|
3.77x
|
12.8%
|
|||
magicJack
|
0.69x
|
0.70x
|
(1.2)%
|
Implied Per Share Equity Value Reference Range for the Company
|
Per Share Merger Consideration
|
|
$6.34 to $8.98
|
$8.71
|
· |
the transaction value, calculated as the enterprise value implied for the target company based on the Per Share Merger Consideration payable in the selected transaction, as a multiple of the target company’s last twelve months revenue, or “LTM revenue” and the target company’s estimated next twelve months revenue, or “NTM revenue,” in each as of the announcement of the relevant transaction and based on publicly available information at that time; and
|
· |
the implied growth rate represented by the target company’s LTM revenue as compared to its NTM revenue.
|
Announcement
Date |
Acquirer
|
Target
|
LTM Revenue
|
NTM Revenue
|
NTM/LTM Revenue Growth
|
|||||
May 1, 2017
|
ESW Capital, LLC
|
Jive Software, Inc.
|
1.7x
|
1.6x
|
0.8%
|
|||||
May 1, 2017
|
IAC/InterActive Corp
|
Angie’s List, Inc.
|
1.8x
|
1.9x
|
(3.0)%
|
|||||
April 10, 2017
|
Sino IC Capital Co., Ltd.
|
Xcerra Corporation
|
1.4x
|
1.2x
|
16.3%
|
|||||
April 10, 2017
|
Highland Clarke Holdings Corp.
|
RetailMeNot, Inc.
|
1.6x
|
1.5x
|
6.5%
|
|||||
December 12, 2016
|
H.I.G. Capital, LLC
|
Lionbridge Technologies, Inc.
|
0.8x
|
0.8x
|
1.8%
|
|||||
August 24, 2016
|
Mill Road Capital Management LLC
|
Skullcandy, Inc.
|
0.7x
|
0.6x
|
17.6%
|
|||||
February 29, 2016
|
II-VI Incorporated
|
Anadigics, Inc.
|
1.1x
|
1.0x
|
9.8%
|
|||||
December 17, 2015
|
TDK Corporation
|
Micronas Semiconductor Holding AG
|
0.5x
|
0.7x
|
(28.5)%
|
|||||
December 1, 2015
|
Beijing E-town Dragon Semiconductor Industry Investment Center (Limited Partnership)
|
Mattson Technology, Inc.
|
1.3x
|
1.9x
|
(29.4)%
|
|||||
November 2, 2015
|
TDK Corporation
|
Hutchinson Technology Incorporated
|
0.9x
|
0.9x
|
(1.3)%
|
|||||
September 3, 2015
|
Diodes Incorporated
|
Pericom Semiconductor Corporation
|
2.0x
|
2.0x
|
4.1%
|
|||||
August 12, 2015
|
Leyard Optoelectronic Co., Ltd.
|
Planar Systems, Inc.
|
0.7x
|
0.7x
|
0.8%
|
|||||
April 30, 2015
|
Knowles Corporation
|
Audience, Inc.
|
0.9x
|
1.2x
|
(26.2)%
|
|||||
April 22, 2015
|
Francisco Partners
|
Procera Networks, Inc.
|
1.7x
|
1.5x
|
13.6%
|
|||||
February 3, 2015
|
MaxLinear, Inc.
|
Entropic Communications, Inc.
|
0.9x
|
1.1x
|
(11.6)%
|
|||||
January 28, 2015
|
Arrow Electronics, Inc.
|
Data Modul AG
|
0.6x
|
0.6x
|
7.6%
|
|||||
September 19, 2014
|
Alegria Beteiligungsgesellschaft mbH
|
First Sensor International AG
|
1.3x
|
1.2x
|
6.8%
|
|||||
July 11, 2014
|
Vishay Intertechnology, Inc.
|
Capella Microsystems Inc.
|
2.6x
|
2.7x
|
(1.7)%
|
|||||
April 27, 2014
|
Exar Corporation
|
Integrated Memory Logic Limited
|
1.5x
|
1.2x
|
16.9%
|
|||||
Median
|
1.27x
|
1.20x
|
1.8%
|
Announcement
Date |
Acquirer
|
Target
|
NTM Revenue
|
|||
July 27, 2017
|
Mitel Networks Corporation
|
ShoreTel, Inc.
|
1.23x
|
|||
August 31, 2016
|
Genesys Telecommunications Laboratories, Inc.
|
Interactive Intelligence Group, Inc.
|
3.11x
|
|||
May 18, 2016
|
NICE-Systems, Ltd.
|
inContact, Inc.
|
3.20x
|
|||
May 5, 2016
|
Vonage Holdings Corp.
|
Nexmo, Inc.
|
n/a
|
|||
April 15, 2016
|
Siris Capital Group, LLC
|
Polycom, Inc.
|
1.05x
|
|||
March 15, 2016
|
magicJack VocalTec Ltd.
|
North American Telecommunications Corporation d/b/a Broadsmart
|
2.56x
|
|||
December 21, 2015
|
ShoreTel, Inc.
|
Corvisa LLC
|
n/a
|
|||
November 23, 2015
|
Comtech Telecommunications Corp.
|
TeleCommunication Systems, Inc.
|
1.10x
|
|||
November 3, 2015
|
Atos SE
|
Unify
|
n/a
|
|||
September 10, 2015
|
Siris Capital Group, LLC
|
Premiere Global Services, Inc.
|
1.70x
|
|||
September 3, 2015
|
Momentum Telecom, Inc.
|
Alteva, Inc.
|
0.70x
|
|||
August 20, 2015
|
Vonage Holdings Corp.
|
iCore Networks, Inc.
|
n/a
|
|||
June 19, 2015
|
RingCentral, Inc.
|
Glip, Inc.
|
n/a
|
|||
June 19, 2015
|
FMR LLC
|
Colt Group S.A.
|
n/a
|
|||
March 2, 2015
|
Mitel Networks Corporation
|
Mavenir Systems, Inc.
|
2.90x
|
|||
November 5, 2014
|
Vonage Holdings Corp.
|
Telesphere Networks Ltd.
|
~2.00x
|
|||
May 6, 2014
|
inContact, Inc.
|
CallCopy, Inc.
|
n/a
|
|||
April 17, 2014
|
Interactive Intelligence Group Inc.
|
OrgSpan Inc.
|
n/a
|
|||
December 17, 2013
|
BroadSoft, Inc.
|
Finocom AG
|
~3.60x
|
|||
November 11, 2013
|
Mitel Networks Corporation
|
Aastra Technologies Limited
|
1.80x
|
|||
November 11, 2013
|
8x8, Inc.
|
Voicenet Solutions, Inc.
|
0.73x
|
|||
October 10, 2013
|
Vonage Holdings Corp.
|
Vocalocity, Inc.
|
1.66x
|
|||
August 13, 2013
|
BroadSoft, Inc.
|
Hosted IP Communications (Europe) Limited
|
~3.00x
|
|||
May 20, 2013
|
Genesys Telecommunications Laboratories, Inc.
|
SoundBite Communications, Inc.
|
2.07x
|
Implied Per Share Equity Value Reference Range for the Company
|
Per Share Merger Consideration
|
|
$7.73 to $10.40
|
$8.71
|
Implied Per Share Equity Value Reference Range (excluding the magicJack Spark Initiative)
|
$6.50 to $7.42
|
Implied Per Share Equity Value Reference Range for the magicJack Spark Initiative
|
$0.44 to $0.69
|
Implied Per Share Equity Value Reference Range
|
Per Share Merger Consideration
|
|
$6.94 to $8.11
|
$8.71
|
Fiscal Year Ending December 31,
|
||||||||||||||||||||
2018 (3)
|
2019
|
2020
|
2021
|
2022
|
||||||||||||||||
(in millions)
|
||||||||||||||||||||
Core Business & Broadsmart
|
||||||||||||||||||||
GAAP Revenue
|
86.3
|
82.8
|
81.4
|
80.8
|
79.9
|
|||||||||||||||
GAAP Operating Income
|
20.6
|
18.6
|
16.7
|
15.1
|
13.1
|
|||||||||||||||
Adjusted EBITDA(1)
|
27.8
|
24.9
|
22.4
|
20.6
|
18.6
|
|||||||||||||||
Spark Initiative(2)
|
||||||||||||||||||||
GAAP Revenue
|
7.7
|
18.2
|
31.9
|
44.3
|
48.8
|
|||||||||||||||
GAAP Operating Income
|
(1.1
|
)
|
8.3
|
20.9
|
32.1
|
35.1
|
||||||||||||||
Adjusted EBITDA(1)
|
(1.1
|
)
|
8.3
|
20.9
|
32.1
|
35.1
|
||||||||||||||
Consolidated
|
||||||||||||||||||||
GAAP Revenue
|
94.0
|
101.0
|
113.3
|
125.1
|
128.7
|
|||||||||||||||
GAAP Operating Income
|
19.5
|
26.9
|
37.6
|
47.2
|
48.2
|
|||||||||||||||
Adjusted EBITDA(1)
|
26.7
|
33.2
|
43.3
|
52.7
|
53.7
|
(1) |
Adjusted EBITDA is a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization adjusted to exclude the impact of certain non-cash and non-recurring items such as stock based compensation expense, severance and restructuring costs, and certain other items. See Non-GAAP Reconciliation of Adjusted EBITDA table below.
|
(2) |
The projections for the Spark initiative used by BofA Merrill Lynch in completing its analysis were discounted to 10% of the projections provided by the Company as presented above.
|
(3) |
The projections did not include any Transaction specific costs or corresponding cash payments including banker fees, legal or professional fees, transaction specific bonuses or other Transaction specific costs.
|
Fiscal Year Ending December 31,
|
||||||||||||||||||||
2018
|
2019
|
2020
|
2021
|
2022
|
||||||||||||||||
(in millions)
|
||||||||||||||||||||
Adjusted EBITDA
|
26.7
|
33.2
|
43.3
|
52.7
|
53.7
|
|||||||||||||||
Depreciation and amortization
|
(2.8
|
)
|
(2.3
|
)
|
(1.8
|
)
|
(1.6
|
)
|
(1.6
|
)
|
||||||||||
Stock-based compensation expense
|
(4.0
|
)
|
(4.0
|
)
|
(3.9
|
)
|
(3.9
|
)
|
(3.9
|
)
|
||||||||||
Severance and transition payments
|
(0.4
|
)
|
||||||||||||||||||
GAAP Income from Operations
|
19.5
|
26.9
|
37.6
|
47.2
|
48.2
|
Name
|
Number of Restricted Shares to Vest
|
Value of Unvested Restricted Shares(2)
|
Number of Option Shares
|
Value of Vested Options
|
|||||||||
Executive Officers(1)
|
|||||||||||||
Don C. Bell III
|
0
|
NA
|
0
|
NA
|
|||||||||
Thomas Fuller
|
0
|
NA
|
0
|
NA
|
|||||||||
Kristin Beischel
|
0
|
NA
|
0
|
NA
|
|||||||||
Dvir Salomon
|
16,666
|
$
|
145,161
|
0
|
NA
|
||||||||
Non-Employee Directors
|
|||||||||||||
Izhak Gross
|
12,775
|
$
|
111,270
|
0
|
NA
|
||||||||
Dr. Yuen Wah Sing
|
8,108
|
$
|
70,620
|
0
|
NA
|
||||||||
Tali Yaron-Elder
|
8,108
|
$
|
70,620
|
0
|
NA
|
||||||||
Richard Harris
|
8,108
|
$
|
70,620
|
0
|
NA
|
||||||||
Alan Howe
|
8,108
|
$
|
70,620
|
0
|
NA
|
||||||||
Directors and executive officers as a group (9 persons)
|
61,873
|
$
|
538,914
|
0
|
NA
|
(1) |
In addition to the payments reflected here for the Company’s current executive officers, a former named executive officer, Jose Gordo, will be entitled to a cash payment of $760,470 upon the acceleration and cancellation of 87,310 restricted shares. See “—Golden Parachute Compensation Payable to Named Executive Officers,” below at page 58.
|
(2) |
Value calculated based on $8.71 per ordinary share as provided in the Merger Agreement for accelerated restricted stock to be cancelled and converted into the right to receive cash.
|
· |
Don C. Bell III Executive Employment Agreement
|
· |
Thomas E.D. Fuller Executive Employment Agreement
|
· |
Kristin Beischel Executive Employment Agreement
|
· |
Dvir Salomon Executive Employment Agreement
|
· |
Jose Gordo Executive Employment Agreement
|
Name
|
Cash Payment
Amounts ($) |
Vesting of
Stock Options ($) |
Vesting of
Restricted Shares ($) |
Total
($) |
|||||||||
Don C. Bell III(1)
|
2,000,000
|
NA
|
NA
|
2,000,000
|
|||||||||
Thomas Fuller(2)
|
500,000
|
NA
|
NA
|
500,000
|
|||||||||
Dvir Salomon(3)
|
574,860
|
NA
|
120,973
|
695,833
|
|||||||||
Kristin Beischel(4)
|
620,833
|
NA
|
NA
|
620,833
|
|||||||||
Jose Gordo(5)
|
907,725
|
NA
|
760,470
|
1,668,195
|
(1) |
Represents the special “single-trigger” lump-sum cash transaction bonus to which Mr. Bell is entitled upon the consummation of the Merger under the Bell Agreement, as amended by the Bell Amendment. Because the Per Share Merger Consideration is less than $9.51 per share, Mr. Bell is not entitled to any severance payment in the event of his termination prior to or following the Transaction in connection with the Transaction. Assumes that Proposal 2 is approved by the shareholders.
|
(2) |
Represents the special “single-trigger” lump-sum cash transaction bonus to which Mr. Fuller is entitled upon the consummation of the Merger under the Fuller Agreement, as amended by the Fuller Amendment. Because the Per Share Merger Consideration is less than $9.51 per share, Mr. Fuller is not entitled to any severance payment in the event of his termination prior to or following the Transaction in connection with the Transaction.
|
(3) |
Represents $162,360 as the special “single-trigger” lump-sum cash transaction bonus to which Mr. Salomon is entitled upon the consummation of the Merger under the Salomon Agreement, and, in the event of his termination by him for good reason or by the Company without cause, the termination payment equal to $275,000 (his base compensation) plus $137,500 (the amount of his annual target bonus).
|
(4) |
Represents $283,333 as the special “single-trigger” lump-sum cash transaction bonus to which Ms. Beischel is entitled upon the consummation of the Merger under the Beischel Agreement, and, in the event of her termination by her for good reason or by the Company without cause, the termination payment equal to $225,000 (her base compensation) plus $112,500 (the amount of her annual target bonus).
|
(5) |
Represents payment due to Mr. Gordo pursuant to his executive employment agreement. This includes a lump-sum change of control payment equal to three times his base salary as of his date of termination less the severance payment paid to Mr. Gordo when he left the Company’s employ in March of 2017, plus acceleration of vesting of 87,310 restricted shares. Although Mr. Gordo still has unvested options which would otherwise be accelerated in connection with the Transaction, the exercise price of those options is $9.33 per share. Accordingly, effective with the consummation of the Merger, these options will be terminated and no payment will be made in connection with them.
|
· |
a dealer in securities or currencies;
|
· |
a trader in securities that elects to use a mark-to-market method of accounting;
|
· |
a bank or other financial institution;
|
· |
an underwriter or insurance company;
|
· |
a regulated investment company;
|
· |
a real estate investment trust;
|
· |
a controlled foreign corporation;
|
· |
persons subject to alternative minimum tax;
|
· |
persons who acquire shares as compensation for services;
|
· |
partnerships or other pass-through entities, and investors in such entities;
|
· |
a tax-exempt organization;
|
· |
a U.S. holder whose functional currency for tax purposes is not the U.S. dollar;
|
· |
a person who owns or is deemed to own 10% or more of our voting stock or of the total value of our stock; or
|
· |
a U.S. expatriate.
|
· |
a citizen or resident individual of the U.S.;
|
· |
a domestic corporation;
|
· |
a domestic partnership;
|
· |
an estate the income of which is subject to U.S. federal income tax regardless of its source; or
|
· |
a trust (a) if a U.S. court can exercise primary supervision over the trust’s administration and one or more U.S. persons are authorized to control all substantial decisions of the trust or (b) that has a valid election in effect under applicable Treasury Regulations to be treated as a U.S. person.
|
· |
due organization, good standing, and corporate power and authority with respect to the execution and delivery of the Merger Agreement;
|
· |
absence of conflicts with, or violations of, organizational documents, applicable laws and contracts, and required consents of governmental authorities;
|
· |
capital structure and ownership of subsidiaries;
|
· |
our filings with the SEC, financial statements and internal controls and procedures;
|
· |
absence of undisclosed liabilities;
|
· |
accuracy and compliance with applicable laws of the information supplied by the Company contained in this proxy statement;
|
· |
absence of certain developments from March 31, 2017 to the date of the Merger Agreement;
|
· |
absence of certain litigation;
|
· |
compliance with applicable laws;
|
· |
material contracts;
|
· |
tax matters;
|
· |
labor and employment matters;
|
· |
employee benefits matters;
|
· |
intellectual property;
|
· |
government grants;
|
· |
real property;
|
· |
environmental matters;
|
· |
customers and suppliers;
|
· |
insurance;
|
· |
transactions with affiliates;
|
· |
compliance with applicable U.S. and foreign export control laws;
|
· |
compliance with anti-corruption and anti-money laundering laws;
|
· |
inapplicability of takeover statutes;
|
· |
opinion from financial advisor;
|
· |
brokers’ fees payable in connection with the Merger;
|
· |
indebtedness;
|
· |
solvency determination; and
|
· |
operating performance.
|
· |
due organization, good standing and corporate power and authority with respect to the execution and delivery of the Merger Agreement;
|
· |
absence of conflicts with, or violations of, organizational documents, applicable laws and contracts, and required consents of governmental authorities;
|
· |
ownership and operations of Merger Sub;
|
· |
accuracy of the information supplied by B. Riley contained in this proxy statement;
|
· |
absence of certain litigation;
|
· |
financing matters;
|
· |
the absence of B. Riley’s and Merger Sub’s ownership of Company shares;
|
· |
brokers’ fees payable in connection with the Merger;
|
· |
shareholder and management arrangements;
|
· |
solvency determination; and
|
· |
approval of the Merger Agreement and the Transaction by B. Riley and Merger Sub.
|
· |
the execution, delivery, announcement or pendency of the Merger Agreement or the Transaction;
|
· |
conditions generally affecting the industry or segments in which the Company and its subsidiaries participate, the Israeli and U.S. economy as a whole or the capital, credit or financial markets in general in the markets which the Company and its subsidiaries have material operations;
|
· |
the failure to take any action by the Company or its subsidiaries which is prohibited by the Merger Agreement;
|
· |
compliance with the terms of, or the taking of any action required by, the Merger Agreement or approved in advance by B. Riley in writing, including any action taken in connection with obtaining regulatory or third party approvals and in compliance with the terms of the Merger Agreement;
|
· |
any change of general applicability after the date of the Merger Agreement in accounting requirements or principles or in applicable laws or the interpretation or enforcement thereof;
|
· |
changes in political conditions in Israel, the United States or any specific country or region in the world where the Company or any of its subsidiaries have operations, or any acts of war (whether or not declared), armed hostilities, sabotage or terrorism occurring after the date of the Merger Agreement or the continuation, escalation or worsening of any such acts of war, armed hostilities, sabotage or terrorism threatened or underway as of the date of the Merger Agreement;
|
· |
any natural disasters, acts of God or force majeure events;
|
· |
the failure of the Company or any of its subsidiaries to meet internal forecasts, budgets or financial projections or any decline in the market price or trading volume of the Company’s shares on the NASDAQ Global Select Market; and
|
· |
any matter set forth in the disclosure schedule.
|
· |
split, combine or reclassify any shares of its capital stock; declare, set aside or pay any dividend or make any other distribution in respect of any shares of its capital stock or other securities, or redeem, repurchase, cancel, or otherwise acquire or offer to redeem, repurchase or otherwise acquire, any of its securities, except as required (or permitted in connection with any net share settlement or tax withholding) by the terms of the Company equity plans or any award agreement thereunder or required by the terms of any other employee benefit plans, arrangements or contracts existing on the date of the Merger Agreement;
|
· |
issue, sell, pledge, grant, transfer, dispose of, enter into any contract with respect to, or encumber any shares of its capital stock or other equity interests or securities exercisable or convertible into, or exchangeable or redeemable for, any such shares or other equity interests, or any rights, warrants, options, calls, or commitments to acquire any such shares or other equity interests, except for issuances or sales of any of the foregoing to the Company or any wholly owned subsidiary of the Company, and issuances of Company shares upon the exercise of Company stock options or upon the vesting of restricted shares, in each case as outstanding on the date of the Merger Agreement;
|
· |
voluntarily adopt or publicly propose a plan of merger, consolidation, complete or partial liquidation or dissolution of the Company or any of its subsidiaries or otherwise enter into any agreements or arrangements imposing changes or restrictions on its assets, operations or businesses that are material to the Company and its subsidiaries taken as a whole;
|
· |
amend its organizational documents;
|
· |
acquire or dispose (directly or indirectly) of any entity or any business or division thereof;
|
· |
incur, assume or guarantee any indebtedness;
|
· |
make any loans or advances to any person, subject to limited exceptions;
|
· |
acquire, transfer, assign, divest, sell, lease, license, permit or suffer to exist the creation of any lien upon, or otherwise dispose of any subsidiary or any material amount of assets, securities or property (including owned intellectual property) except as permitted pursuant to contracts existing as of the date of the Merger Agreement;
|
· |
abandon or allow any material owned intellectual property to lapse or expire;
|
· |
settle any action against the Company or any of its subsidiaries (other than actions arising in connection with the Merger Agreement or the transactions contemplated thereby), other than as excepted by the terms of the Merger Agreement;
|
· |
materially change its accounting or tax reporting methods, principles or policies, except as may be required by law or GAAP;
|
· |
make, change or revoke any material tax election, file any amended tax return, enter into any closing agreement with respect to taxes, settle any material tax claim, audit, assessment or dispute, surrender any right to claim a refund of a material amount of taxes, take any action which is reasonably likely to result in a material increase in the tax liability of the Company or its subsidiaries, or, in respect of any taxable period (or portion thereof) ending after the closing date, the tax liability of B. Riley or its affiliates;
|
· |
make or authorize certain capital expenditures;
|
· |
assign, transfer, lease, cancel, fail to renew or fail to extend any permit issued by the FCC or any other governmental authority or discontinue any operations that require prior regulatory approval for discontinuance;
|
· |
enter into any line of business in any geographic area other than the lines of business of the Company and its subsidiaries as of the date of the Merger Agreement;
|
· |
enter into any contract that would have been a material contract or real property lease had it been entered into prior to the Merger Agreement, or amend, modify or terminate any material contract or real property lease in any material respect, other than expirations of any such material contract in the ordinary course of business in accordance with the terms of such contract;
|
· |
other than as required by any contract or benefit plan in existence as of the date of the Merger Agreement, (i) increase the amount of compensation or benefits payable to any employee, officer, individual independent contractor or director of the Company or any of its subsidiaries, including as a result of making any promotion, changing job titles or reclassifying any employee, officer, individual independent contractor or director of the Company or any of its subsidiaries, other than annual increases in employees’ wage or salary, in the ordinary course of business, consistent with past practice, with respect to any employee whose annual compensation is not in excess of $100,000 and which increases do not exceed 5% for any individual employee or 3% for all employees of the Company and its subsidiaries, (ii) grant any rights to or pay any severance or termination pay to, or enter into any employment or severance agreement with, any director, officer or other employee of the Company or any of its subsidiaries, (iii) take any action to amend or waive any vesting criteria or accelerate vesting, exercisability or funding under any benefit plan or award granted thereunder, (iv) grant any new awards, or amend or modify the terms of any outstanding awards, under any benefit plan, (v) forgive any loans or issue any loans (other than routine travel advances issued in the ordinary course of business) to any employee of the Company or its subsidiaries, (vi) hire any employee or engage any independent contractor (who is a natural person) with an annual salary or wage rate or consulting fees in excess of $100,000 individually, (vii) terminate the employment of any officer other than for cause; (viii) become a party to, establish, adopt, terminate or amend in any material respect any benefit plan or any similar arrangement; or (ix) become a party to any consulting contract, other than any such contract that can be terminated on 30 days’ or fewer notice and without payment of a penalty;
|
· |
become a party to, establish, adopt, amend, commence participation in or terminate any collective bargaining agreement or other agreement with a labor union, works council or similar organization;
|
· |
make any written or oral communications to the directors, officers or employees of the Company or any of its subsidiaries addressing how existing compensation or benefit matters will or may be affected by the Transaction prior to providing B. Riley with a copy of the intended communication; provided, that B. Riley will be allowed a reasonable period of time to review and comment on the communication, and the Company will consider any such comments in good faith; or
|
· |
authorize any of, or commit or agree to take any of, the foregoing actions.
|
· |
cause the Company to provide B. Riley at least four business days’ prior written notice advising B. Riley that it intends to take such action, which notice must (i) state that the Company has received a superior proposal or an intervening event has occurred, (ii) specify the material terms and conditions of such superior proposal, or the material facts and circumstances related to such intervening event, (iii) in the case of a superior proposal, identify the person making such superior proposal, to the extent not previously identified and (iv) in the case of a superior proposal, enclose the most recent draft of any agreements intended to be entered into with the person making such superior proposal;
|
· |
cause the Company to negotiate, to the extent B. Riley so wishes to negotiate, during the four business day period following delivery of the notice of a superior proposal or an intervening event, in good faith with B. Riley concerning any revisions to the terms of the Merger Agreement that B. Riley proposes in response to such superior proposal or intervening event, and
|
· |
after complying with these requirements, determine that, in the case of a superior proposal, such acquisition proposal continues to constitute a superior proposal, and in the case of an intervening event, such intervening event continues to materially adversely affect the advisability of the Merger Agreement and the Merger to the Company from a financial point of view, in each case after giving due consideration to any changes proposed to be made to the Merger Agreement by B. Riley in writing.
|
· |
obtain from any third party and/or any governmental authority any consent, approval, authorization, waiver, or order required to be obtained or made by any party, and avoid any action by any governmental authority, in connection with the Merger and to fulfill the conditions to the Transaction; and
|
· |
make all necessary filings with, and thereafter make any other required submissions to, any governmental authority required under applicable law, including the HSR Act, the Communications Act and any applicable state communications laws, in connection with the Merger and to fulfill the conditions to the Transaction.
|
· |
causing a merger proposal (in the Hebrew language) to be executed in accordance with Section 316 of the ICL;
|
· |
delivering the merger proposal to the Companies Registrar in accordance with Section 317(a) of the ICL;
|
· |
causing a copy of the merger proposal to be delivered to any of the Company’s secured creditors; and
|
· |
promptly informing the Companies Registrar, in accordance with Section 317(b) of the ICL, that notice was given to creditors, if any, under Section 318 of the ICL.
|
· |
approval by the Company’s shareholders of the Merger Proposal;
|
· |
all applicable waiting periods under the HSR Act having expired or been terminated;
|
· |
no governmental authority having enacted, entered, or enforced any order or law which is in effect and restrains, prohibits, declares unlawful or enjoins the consummation of the Transaction;
|
· |
at least 50 days having elapsed after the filing of the merger proposal with the Companies Registrar and at least 30 days having elapsed after the approval of the Merger Proposal by the shareholders of each of the Company and Merger Sub; and
|
· |
all authorizations, approvals, clearances and consents of or filings with the FCC or any state regulators required to be procured or made in connection with the Transaction having been procured or made.
|
· |
the representations and warranties of the Company contained in the Merger Agreement, as of the date of the Merger Agreement and as of the closing date (except to the extent such representations and warranties relate to an earlier date, in which case as of such earlier date), with respect to (i) corporate authority, capitalization and no material adverse effect being true and correct in all respects (except in the case of capitalization, for de minimis inaccuracies), (ii) standing and corporate power, takeover laws, the financial advisor opinion and the absence of brokers being true and correct in all material respects, and (iii) all other representations of the Company being true and correct (without giving effect to materiality qualifications or limitations), except to the extent any failures of (iii) would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect (as defined in the Merger Agreement);
|
· |
the Company having performed, or complied with, in all material respects all obligations required to be performed by or complied with by it under the Merger Agreement at or prior to the closing date;
|
· |
B. Riley having received at the closing of the Merger a certificate signed by an executive officer of the Company certifying as to the satisfaction of the conditions set forth in the two immediately preceding bullets;
|
· |
the approval required to be obtained from the IIA having been granted;
|
· |
all authorizations, approvals, clearances and consents, and all expirations or terminations of waiting periods (including any extensions thereof), in each case required to be obtained from a governmental authority in connection with the Transaction having been obtained or having occurred, in each case without the imposition of a condition that is not contingent on the consummation of the Merger or that would reasonably be expected to have a material adverse effect on the business, results of operations or financial condition of the Company and its subsidiaries (taken as a whole) or Parent and its subsidiaries (taken as a whole, after giving effect to the Merger) measured on a scale relative to the Company and its subsidiaries (see “—Efforts to Obtain Regulatory Approvals and Tax Ruling” beginning on page 71); and
|
· |
the Company or its subsidiaries having filed the tax returns specified in the Merger Agreement.
|
· |
the representations and warranties of Parent and Merger Sub contained in the Merger Agreement being true and correct (without giving effect to materiality qualifications or limitations) on and as of the date of the Merger Agreement and as of the closing date (except to the extent such representations and warranties relate to a specified date, in which case as of such specified date), except for failures that, individually or in the aggregate, would not reasonably be expected to prevent, materially delay or materially impair the consummation of the Transaction or the performance by Parent or Merger Sub of their obligations under the Merger Agreement;
|
· |
B. Riley and Merger Sub having performed, or complied with, in all material respects, all obligations required to be performed by or complied with by it under the Merger Agreement on or prior to the closing date;
|
· |
the Company having received at the closing of the Merger a certificate signed by an executive officer of B. Riley and Merger Sub certifying as to the satisfaction of the conditions set forth in the two immediately preceding bullets;
|
· |
B. Riley having transferred the aggregate amount of consideration due with respect to the Company shares (other than excluded shares), stock options and restricted shares in accordance with the terms of the Merger Agreement; and
|
· |
B. Riley Principal Investments having executed an undertaking in customary form in favor of the IIA to comply with the provisions of the R&D Law.
|
· |
by mutual written consent of the Company and B. Riley;
|
· |
by either B. Riley or the Company, if:
|
- |
the Merger has not been consummated on or before August 9, 2018, provided that if the condition to closing, solely in respect of the approval by or in connection with U.S. executive branch agencies that review FCC applications for national security and other issues, including the U.S. Department of Justice, Federal Bureau of Investigation, Department of Homeland Security, and National Security Agency, has not been satisfied or waived on or prior to such date, but all other conditions to closing have been satisfied or waived (other than those conditions that by their nature are to be satisfied at the closing, but subject to the satisfaction or (to the extent permitted by law) waiver of those conditions), then the End Date will automatically be extended to November 9, 2018, and provided further, however, that the right to terminate the Merger Agreement will not be available to any party whose breach or failure to perform or comply with any obligation under the Merger Agreement resulted in or was a proximate cause of the failure of the Merger to be consummated on or before the End Date;
|
- |
any governmental authority of competent jurisdiction, located in the United States, Israel or in another jurisdiction outside of the United States in which the Company or any of its subsidiaries, or B. Riley or any of its subsidiaries, engage in material business activities, has enacted, entered or enforced any order or law permanently enjoining, restraining, prohibiting or making illegal the consummation of the Merger, which order or law must have become final and non-appealable; provided, however, that (i) the party seeking to terminate the Merger Agreement will have complied with its obligation to seek the requisite approval of governmental authorities as set forth in the Merger Agreement, including, with respect to B. Riley, using its commercially reasonable efforts to remove any order and otherwise using its reasonable best efforts, as set forth in the Merger Agreement, and (ii) the right to terminate the Merger Agreement will not be available to any party whose breach or failure to perform or comply with any obligation under the Merger Agreement resulted in or was a proximate cause of the issuance of such order or law; or
|
- |
the requisite approval of the Company’s shareholders is not obtained at the Company shareholders meeting or at any adjournment or postponement thereof;
|
· |
by B. Riley if:
|
- |
the Company has violated or breached any covenant, representation, or warranty contained in the Merger Agreement (other than in relation to financing cooperation), which has prevented or would prevent the satisfaction of any condition to the obligations of B. Riley and Merger Sub to complete the Merger, and is not capable of being cured by the End Date or, to the extent so curable, has not been cured by the Company within the earlier of 30 days after receiving written notice from B. Riley describing such violation or breach, or three business days prior to the End Date; or
|
- |
the Board has effected a Company adverse recommendation change or, at any time following receipt of an acquisition proposal, the Board fails to reaffirm its approval or recommendation of the Merger Proposal as promptly as practicable (but in any event within five business days) after receipt of any written request to do so from B. Riley;
|
· |
by the Company if:
|
- |
B. Riley or Merger Sub has violated or breached any covenant, representation, or warranty contained in the Merger Agreement, which has prevented or would prevent the satisfaction of any condition to the obligation of the Company to complete the Merger, and is not capable of being cured by the End Date or, to the extent so curable, has not been cured by B. Riley and Merger Sub within the earlier of 30 days after receiving written notice from the Company describing such violation or breach, or three business days prior the End Date; or
|
- |
prior to the time at which the requisite Company shareholder approval has been obtained, in response to a superior proposal that was not solicited in material violation of the Merger Agreement, the Company enters into a definitive alternative acquisition agreement with respect to an acquisition proposal that the Board has concluded constitutes a superior proposal, subject to payment of any fees required prior to or concurrently with such termination.
|
· |
the Merger Agreement is terminated (i) by B. Riley after a Company adverse recommendation change or (ii) by the Company in order to enter into a definitive agreement relating to a superior proposal;
|
· |
the Merger Agreement is terminated (i) by either party because the closing has not occurred by the End Date, (ii) by either party because Company shareholder approval of the Merger Proposal is not obtained or (iii) by B. Riley because of a violation or breach of the Merger Agreement by the Company which has prevented or would prevent the satisfaction of any condition to the obligations of B. Riley and Merger Sub to complete the Merger, and in any such case (a) at any time after the date of the Merger Agreement and prior to the termination of the Merger Agreement, an acquisition proposal has been made to the Company or any of its subsidiaries or its shareholders or has been publicly announced and such acquisition proposal has not been publicly withdrawn on a bona fide basis and (b) within twelve (12) months after such termination, the Company enters into a definitive agreement with respect to an acquisition proposal that is thereafter consummated, or will have consummated or will have approved or recommended to the Company’s shareholders or otherwise not opposed, an acquisition proposal that is thereafter consummated (provided that for the purposes of (b), references to “20%” in the definition of acquisition proposal are deemed to be references to “50%”).
|
· |
the Company’s Board determines that, considering the anticipated change in the financial position of the merging companies upon effectiveness of the permitted assignment, no reasonable concern exists that the Surviving Corporation will be unable to fulfill the obligations of the Surviving Corporation to its creditors;
|
· |
the proposed assignment would not reasonably be expected to materially delay or significantly increase the risk of not obtaining the expiration or termination of applicable waiting periods under the HSR Act (or any extensions thereof), significantly increase the risk of any governmental authority entering an order prohibiting the consummation of the Merger, or significantly increase the risk of not being able to remove any such order on appeal or otherwise;
|
· |
the proposed assignee is an entity organized under the laws of any state of the United States;
|
· |
the proposed assignee consents in writing to assume all obligations of B. Riley under the Merger Agreement;
|
· |
the proposed assignee affirms in writing that all representations and warranties made in the Merger Agreement with respect to B. Riley as of the date of the Merger Agreement will be deemed representations and warranties made with respect to the proposed assignee as of the date of such assignment, subject to limited exceptions;
|
· |
Merger Sub, which upon the permitted assignment becoming effective must be a wholly owned direct or indirect subsidiary of the proposed assignee, re-affirms in writing that all representations and warranties made in the Merger Agreement with respect to Merger Sub as of the date of the Merger Agreement will be deemed representations and warranties made with respect to Merger Sub as of the date of such assignment;
|
· |
no assignment will relieve B. Riley of any of its obligations pursuant to the Merger Agreement; and
|
· |
B. Riley delivers to the Company a written notice of consummation of the permitted assignment, together with the true, correct and complete assignment documents containing evidence that the conditions to the permitted assignment have been satisfied.
|
· |
the rights of the indemnified persons to enforce the obligations described under “—Indemnification and Insurance;”
|
· |
the right of the Company’s shareholders to enforce B. Riley’s obligation to pay the Per Share Merger Consideration; and
|
· |
other rights expressly set forth in the Merger Agreement.
|
Company
Ordinary Shares |
||||||||
High
|
Low
|
|||||||
Fiscal Year Ending December 31, 2018
|
||||||||
First Quarter (through February 6, 2018)
|
$
|
8.55
|
$ |
8.30
|
||||
Fiscal Year Ending December 31, 2017
|
||||||||
First Quarter
|
$
|
8.90
|
$
|
6.85
|
||||
Second Quarter
|
$
|
8.75
|
$
|
6.25
|
||||
Third Quarter
|
$
|
8.20
|
$
|
6.70
|
||||
Fourth Quarter
|
$
|
8.55
|
$
|
5.55
|
||||
Fiscal Year Ending December 31, 2016
|
||||||||
First Quarter
|
$
|
9.38
|
$
|
6.22
|
||||
Second Quarter
|
$
|
6.85
|
$
|
5.47
|
||||
Third Quarter
|
$
|
6.87
|
$
|
5.27
|
||||
Fourth Quarter
|
$
|
7.60
|
$
|
5.65
|
||||
Fiscal Year Ending December 31, 2015
|
||||||||
First Quarter
|
$
|
8.67
|
$
|
6.50
|
||||
Second Quarter
|
$
|
8.43
|
$
|
6.48
|
||||
Third Quarter
|
$
|
9.99
|
$
|
6.72
|
||||
Fourth Quarter
|
$
|
12.50
|
$
|
8.76
|
· |
Annual cash compensation for each non-employee director in the amount of $50,000 or, in the case of the non-employee Chairman of the Board, $100,000, paid quarterly;
|
· |
Annual equity-based compensation valued at $60,000 per year for each non-employee director, which will fully vest on the first anniversary of the date of grant;
|
· |
Annual cash compensation of $10,000 for service on each of the Company’s Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee; and
|
· |
Annual cash compensation of $10,000 for service on a “special committee” of the Board, intended to cover up to four meetings per year, with additional cash compensation of $1,000 for each additional meeting thereafter.
|
· |
GTT Communications Inc
|
· |
Shenandoah Telecommun Co
|
· |
Cogent Communications Hldgs
|
· |
Iridium Communications Inc
|
· |
Atn International Inc
|
· |
Hawaiian Telcom Holdco Inc
|
· |
Inteliquent Inc
|
· |
LogMeIn Inc
|
· |
Incontact Inc
|
· |
Demandware Inc
|
· |
8x8 Inc
|
· |
LivePerson Inc
|
· |
Alaska Communications Sys Gp
|
· |
Lumos Networks Corp
|
· |
ORBCOMM Inc
|
· |
Spok Holdings Inc
|
· |
Limelight Networks Inc
|
· |
Five9 Inc
|
· |
Boingo Wireless Inc
|
· |
Brightcove Inc
|
· |
Synacor Inc
|
· |
Fusion Telecommunications
|
· |
Ooma Inc
|
Executive
|
Target/Maximum
Annual Bonus |
Bonus Milestones:
|
Bonus Payout Levels
|
|||
Don Carlos Bell III
|
Target of $500,000
|
50% based on meeting at least 80% and up to 120% of target revenue for the year
|
Revenue: Range from 35% to 200% of the target annual bonus.
|
|||
50% based on meeting at least 80% and up to 120% of target EBITDA for the year
|
EBITDA: Range from 35% to 200% of the target annual bonus.
|
|||||
Thomas Fuller
|
Target of $206,250
|
50% based on meeting at least 80% and up to 120% of target revenue for the year
|
Revenue: Range from 35% to 200% of the target annual bonus.
|
|||
50% based on meeting at least 80% and up to 120% of target EBITDA for the year
|
EBITDA: Range from 35% to 200% of the target annual bonus.
|
|||||
Kristin Beischel
|
Target of $112,500
|
50% based on meeting at least 80% and up to 120% of target revenue for the year
|
Revenue: Range from 35% to 200% of the target annual bonus.
|
|||
50% based on meeting at least 80% and up to 120% of target EBITDA for the year
|
EBITDA: Range from 35% to 200% of the target annual bonus.
|
|||||
Dvir Salomon
|
Target of $137,500
|
50% based on meeting at least 80% and up to 120% of target revenue for the year
|
Revenue: Range from 35% to 200% of the target annual bonus.
|
|||
50% based on meeting at least 80% and up to 120% of target EBITDA for the year
|
EBITDA: Range from 35% to 200% of the target annual bonus.
|
Name and Principal Position
|
Year
|
Salary
($) |
Bonus
($) |
Stock Awards
($)(1) |
Option Awards
($)(1) |
Non-Equity Incentive
Plan Compensation ($)(2)
|
All Other Compensation ($)
|
Total
($) |
||||||||
(a)
|
(b)
|
(c)
|
(d)
|
(e)
|
(f)
|
(g)
|
(i)
|
(j)
|
||||||||
Don Carlos Bell, III
|
||||||||||||||||
Chief
|
2017
|
405,449
|
-
|
1,244,718
|
4,003,029
|
449,000
|
500,000
|
(3)
|
6,602,196
|
|||||||
Executive Officer,
|
2016
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||
and President
|
2015
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||
Thomas Fuller
|
||||||||||||||||
Chief
|
2017
|
220,882
|
-
|
311,179
|
1,000,757
|
185,213
|
275,000
|
(4)
|
1,993,031
|
|||||||
Financial
|
2016
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||
Officer
|
2015
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||
Dvir Salomon
|
||||||||||||||||
Chief
|
2017
|
287,500
|
-
|
-
|
373,199
|
121,911
|
93,681
|
(5)
|
876,291
|
|||||||
Technology
|
2016
|
25,000
|
-
|
607,000
|
-
|
125,000
|
225,000
|
(5)
|
982,000
|
|||||||
Officer
|
2015
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||
Kristen Beischel
|
||||||||||||||||
Chief
|
2017
|
182,590
|
-
|
176,335
|
567,096
|
101,026
|
151,400
|
(6)
|
1,178,447
|
|||||||
Marketing
|
2016
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||
Officer
|
2015
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||
Gerald Vento
|
||||||||||||||||
Former Chief
|
2017
|
94,872
|
-
|
-
|
-
|
-
|
820,591
|
(7)
|
915,463
|
|||||||
Executive Officer,
|
2016
|
500,000
|
-
|
-
|
-
|
406,500
|
-
|
906,500
|
||||||||
and President(3)
|
2015
|
500,000
|
-
|
-
|
-
|
706,063
|
-
|
1,206,063
|
||||||||
Jose Gordo
|
||||||||||||||||
Former Chief
|
2017
|
132,436
|
-
|
-
|
-
|
-
|
525,796
|
(8)
|
658,232
|
|||||||
Financial
|
2016
|
350,000
|
-
|
-
|
-
|
142,275
|
4,269
|
(8)
|
496,544
|
|||||||
Officer(4)
|
2015
|
325,000
|
-
|
1,800,000
|
1,801,138
|
211,819
|
-
|
4,137,957
|
(1) |
The amounts in these columns reflect the aggregate grant date fair value of the stock awards computed based on the closing adjusted price as of the grant date and for option awards computed based on the Black-Scholes value as of the grant date in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, “Stock-based Compensation.” For additional information, see note 12 to the audited consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.
|
(2) |
The amounts in 2016 and 2015 represent the annual cash incentive bonuses paid in 2017 and 2016, respectively, to Messrs. Vento, Gordo and Salomon based on the bonus milestones achieved during the years ended December 31, 2016 and 2015, respectively. There were no annual cash incentive bonuses paid to Messrs. Vento and Gordo for the year ended December 31, 2017. The amounts in 2017 represent the estimated annual cash incentive bonus to be paid to Messrs. Bell, Fuller and Salomon and Ms. Beischel for the year ended December 31, 2017 based on the latest calculation of the bonus milestones achieved. These amounts are still subject to Board approval prior to payment.
|
(3) |
Mr. Bell received a signing bonus of $500,000 in 2017.
|
(4) |
Mr. Fuller received a signing bonus of $275,000 in 2017.
|
(5) |
Mr. Salomon received $8,829 in health-related benefits in 2017 as well as $84,852 in expense reimbursements related to his relocation to the United States from Israel. In 2016 Mr. Salomon received $225,000 in indirect compensation from our Israeli parent to the consulting company which employed Mr. Salomon before we acquired that consulting company and Mr. Salomon became an employee of magicJack in the United States.
|
(6) |
Ms. Beischel received a signing bonus of $150,000 in 2017 as well as $1,400 in health-related benefits.
|
(7) |
Mr. Vento retired as President and Chief Executive Office of the Company effective March 9, 2017, and resigned from the Board of Directors on June 17, 2017. Mr. Vento received $800,000 in consulting fees and $20,591 in non-employee Director fees in 2017.
|
(8) |
Mr. Gordo left the Company effective May 25, 2017. In connection with his departure, he executed a separation agreement and received $525,000 in severance. Additionally, Mr. Gordo received $796 and $4,269 in health-related benefits in 2017 and 2016 respectively.
|
Estimated Future Payouts Under Non-Equity Incentive Plan Awards(1)
|
||||||||||||||||||||||||||||||||
Grant
|
Threshold
|
Target
|
Maximum
|
All Other Stock Awards: Number of Shares of Stock or Stock Units
|
All Other Option Awards: Number of Securities Underlying Options
|
Exercise or Base Price of Option Awards
|
Grant Date Fair Value of Stock and Option Awards
|
|||||||||||||||||||||||||
Name
|
Date
|
($)
|
($)
|
($)
|
(#)
|
|
(#)
|
($)
|
($)
|
|||||||||||||||||||||||
Don Carlos Bell, III
|
05/08/17
|
175,000
|
500,000
|
1,000,000
|
149,068
|
1,883,165
|
9.51
|
5,247,747
|
||||||||||||||||||||||||
Thomas Fuller
|
05/08/17
|
72,188
|
206,250
|
412,500
|
37,267
|
470,791
|
9.51
|
1,311,936
|
||||||||||||||||||||||||
Dvir Salomon
|
05/08/17
|
-
|
125,000
|
-
|
-
|
175,566
|
9.51
|
373,199
|
||||||||||||||||||||||||
Kristen Beischel
|
05/08/17
|
39,375
|
112,500
|
225,000
|
21,118
|
266,782
|
9.51
|
743,432
|
||||||||||||||||||||||||
Gerald Vento
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
Jose Gordo
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(1) |
These columns reflect the threshold, target and maximum amounts that Messrs. Bell, Fuller and Salomon and Ms. Beischel were eligible to receive under our annual cash incentive bonus plan with respect to fiscal year 2017. Messrs. Vento and Gordo were not eligible to receive an award under the annual cash incentive bonus plan for fiscal year 2017. Awards paid for 2016 are reflected in the Summary Compensation Table, above.
|
Option Award
|
Stock Awards
|
|||||||||||||||||||||||
Name
|
Number of
Securities Underlying Unexercised Options (#) Exercisable |
Number of
Securities Underlying Unexercised Options (#) Unexercisable |
Option
Exercise Price ($) |
Option
Expiration Date |
Number of
Shares or Units of Stock That Have Not Vested (#)(1) |
Market Value
of Shares or Units of Stock That Have Not Vested ($)(2) |
||||||||||||||||||
Don Carlos Bell, III
|
-
|
1,883,165
|
9.51
|
05/08/22
|
149,068
|
1,259,625
|
||||||||||||||||||
Thomas Fuller
|
-
|
470,791
|
9.51
|
05/08/22
|
37,267
|
314,906
|
||||||||||||||||||
Dvir Salomon
|
-
|
175,566
|
9.51
|
05/08/22
|
16,666
|
140,828
|
||||||||||||||||||
Kristen Beischel
|
-
|
266,782
|
9.51
|
05/08/22
|
21,118
|
178,447
|
||||||||||||||||||
Gerald Vento(3)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Jose Gordo(4)
|
-
|
-
|
-
|
-
|
-
|
-
|
(1) |
All shares in this column consist of restricted stock awards. The awards granted to Messrs. Bell and Fuller and to Ms. Beischel are scheduled to vest in one-third increments on each of May 8, 2018, March 9, 2019 and March 9, 2020. If the contemplated change-in-control event is culminated, none of these awards will vest. The awards for Mr. Salomon are scheduled to vest on December 31, 2018. The vesting would be accelerated if the contemplated change-in-control is approved and the transaction completed.
|
(2) |
Amounts in this column have been calculated using an assumed stock price of $8.45, the closing price of our ordinary shares on December 29, 2017, the last business day of our fiscal year 2017.
|
(3) |
On June 18, 2017, Mr. Vento and the Company entered into an agreement to amend his Consulting Agreement. In connection with that amendment, Mr. Vento surrendered to the Company the options to purchase 722,782 shares at an exercise price of $14.95 per share. Accordingly, the option was terminated effective June 18, 2017, and excluded from this schedule.
|
(4) |
In connection with Mr. Gordo’s departure from the Company, 106,907 options with a strike price of $9.33 vested in May 2017, and were scheduled to expire on November 25, 2017 absent a change-in-control event. Additionally, 225,964 remaining unvested stock options that were originally scheduled to vest in annual increments on December 31, 2017 and 2018 were forfeited, unless there was a Change of Control within 180 days of his termination date. Furthermore, 87,310 shares underlying a restricted stock award made in 2015 remained unvested and were not scheduled to vest, unless there was a Change of Control within 180 days of Mr. Gordo’s termination. The contemplated transaction qualifies as a Change of Control, and if finalized will trigger the vesting of these awards. As the options are at a strike price higher than the proposed purchase price, Mr. Gordo’s options have no value. The 87,310 shares that would vest upon a change-in-control have a market value of $737,770 at December 31, 2017. In connection with his termination, Mr. Gordo surrendered to the Company options originally granted on May 8, 2013 covering 296,031 shares at an exercise price of $17.63.
|
Stock Awards
|
||||||||
Name
|
Number of Shares
Acquired on Vesting (#) |
Value Realized
on Vesting ($)(1) |
||||||
Don Carlos Bell, III
|
-
|
-
|
||||||
Thomas Fuller
|
-
|
-
|
||||||
Dvir Salomon
|
16,667
|
140,836
|
||||||
Kristen Beischel
|
-
|
-
|
||||||
Gerald Vento
|
-
|
-
|
||||||
Jose Gordo
|
76,211
|
495,372
|
(1) |
The aggregate dollar amount realized by the Named Executive Officer upon the vesting of shares of our restricted stock was computed by multiplying the number of shares of our restricted stock that vested by the market value of the underlying shares on the last date the market was open prior to the vesting date. The amount for Mr. Salomon was calculated using an assumed stock price of $8.45, the closing price of our ordinary shares on December 29, 2017, the last business day prior to the vesting date of December 31, 2017. The amount for Mr. Gordo was calculated using an assumed stock price of $6.50, the closing price on the vesting date of May 25, 2017, the date of his separation.
|
(i) |
Upon termination of Mr. Vento’s employment prior to a Change of Control, by Mr. Vento for Good Reason or by the Company without Cause (as defined in the Vento Agreement), Mr. Vento will be entitled to a termination payment equal to the sum of (a) Mr. Vento’s annual base salary at the time of such termination and (b) Mr. Vento’s Target Annual Bonus for the fiscal year in which his employment is terminated (as if the applicable performance criteria have been met at the level that would result in payment of the Target Annual Bonus at the 100% level irrespective of whether or not that is the case);
|
(ii) |
Upon termination of Mr. Vento’s employment by the resignation of Mr. Vento without Good Reason or by the Company with Cause, death or disability or for any other reason except as provided in the immediately preceding paragraph above or the immediately following paragraphs below, Mr. Vento will be due no further compensation other than what is due and owing through the effective date of Mr. Vento’s resignation or termination (including any Annual Bonus that may be due and payable to Mr. Vento);
|
(iii) |
If upon or within six months subsequent to a Change of Control, Mr. Vento’s employment is terminated by Mr. Vento for Good Reason or by the Company without Cause, Mr. Vento will be entitled to and paid a termination payment equal to three times the sum of (a) Mr. Vento’s annual base salary at the time of such termination and (b) Mr. Vento’s Target Annual Bonus for the fiscal year in which his employment is terminated (as if the applicable performance criteria have been met at the level that would result in payment of the Target Annual Bonus at the 100% level irrespective of whether or not that is the case); or
|
(iv) |
If Mr. Vento’s employment is terminated by Mr. Vento for Good Reason or by the Company without Cause 180 days prior to the Company’s execution of an agreement which, if consummated, would constitute a Change of Control, then upon consummation of such Change of Control, Mr. Vento will receive an additional payment equal to the difference between (a) the change of control termination payment described in clause (iii) and (b) any termination payment previously provided to Mr. Vento as described in clause (i).
|
(i) |
Upon termination prior to a Change of Control by the Company without Cause or by Mr. Gordo for Good Reason, each as defined in the Gordo Agreement, Mr. Gordo will be entitled to a termination payment equal to the sum of (a) Mr. Gordo’s annual base salary at the time of such termination and (b) Mr. Gordo’s Target Annual Bonus for the fiscal year in which his employment is terminated (as if the applicable performance criteria have been met at the level that would result in payment of the Target Annual Bonus at the 100% level irrespective of whether or not that is the case);
|
(ii) |
Upon termination of Mr. Gordo’s employment by the resignation of Mr. Gordo without Good Reason or by the Company with Cause, death or disability or for any other reason except as provided in the immediately preceding paragraph above or the immediately following paragraphs below, Mr. Gordo will be due no further compensation other than what is due and owing through the effective date of Mr. Gordo’s resignation or termination (including any Annual Bonus that may be due and payable to Mr. Gordo);
|
(iii) |
If upon or within six months subsequent to a Change of Control, Mr. Gordo’s employment is terminated by Mr. Gordo for Good Reason or by the Company without Cause, Mr. Gordo will be entitled to and paid a termination payment equal to three times the sum of (a) Mr. Gordo’s annual base salary at the time of such termination and (b) Mr. Gordo’s Target Annual Bonus for the fiscal year in which his employment is terminated (as if the applicable performance criteria have been met at the level that would result in payment of the Target Annual Bonus at the 100% level irrespective of whether or not that is the case); or
|
(iv) |
If Mr. Gordo’s employment is terminated by Mr. Gordo for Good Reason or by the Company without Cause 180 days prior to the Company’s execution of an agreement which, if consummated, would constitute a Change of Control, then upon consummation of such Change of Control, Mr. Gordo will receive an additional payment equal to the difference between (a) the change of control termination payment described in clause (iii) and (b) any termination payment previously provided to Mr. Gordo as described in clause (i).
|
(i) |
Upon termination of Mr. Bell’s employment prior to a change of control by Mr. Bell for good reason or by the Company without cause (as each term is defined in the Bell Agreement), Mr. Bell will be entitled to a termination payment equal to two times Mr. Bell’s annual base salary at the time of such termination (the “Termination Payment”).
|
(ii) |
Upon termination of Mr. Bell’s employment by the resignation of Mr. Bell without good reason or by the Company with cause or by reason of death or disability or for any other reason except as provided in the immediately preceding paragraph above or the immediately following paragraph below, Mr. Bell will be due no further compensation other than what is due and owing through the effective date of Mr. Bell’s resignation or termination (including any Annual Bonus that may be due and payable to Mr. Bell).
|
(iii) |
If upon or within six months subsequent to a change of control, Mr. Bell’s employment is terminated by Mr. Bell for good reason or by the Company without cause, Mr. Bell will be entitled to and be paid a termination payment (the “Change of Control Payment”) equal to two times the sum of (a) Mr. Bell’s annual base salary at the time of such termination and (b) Mr. Bell’s Target Annual Bonus for the fiscal year in which his employment is terminated (as if the applicable performance criteria have been met at the level that would result in payment of the Target Annual Bonus at the 100% level irrespective of whether or not that is the case); provided, however, that the Change of Control Payment will only be paid to Mr. Bell if the change of control closes after the six month anniversary of the execution date of the Bell Agreement and the change of control transaction meets a per share threshold price that is greater than or equal to $9.51 per share. In the event a change of control transaction closes in the first six months following the execution date of the Bell Agreement, or closes pursuant to an agreement entered into in the first six months following the execution date of the Bell Agreement, Mr. Bell will not be entitled to the Change of Control Payment upon his termination.
|
(i) |
Upon termination of Mr. Fuller’s employment prior to a change of control by Mr. Fuller for good reason or by the Company without cause (as each term is defined in the Fuller Agreement), Mr. Fuller will be entitled to a termination payment equal to one times the sum of (a) Mr. Fuller’s annual base salary at the time of such termination and (b) Mr. Fuller’s target annual bonus for the fiscal year in which his employment is terminated.
|
(ii) |
Upon termination of Mr. Fuller’s employment by the resignation of Mr. Fuller without good reason or by the Company with cause or by reason of death or disability or for any other reason except as provided in the immediately preceding paragraph above or the immediately following paragraph below, Mr. Fuller will be due no further compensation other than what is due and owing through the effective date of Mr. Fuller’s resignation or termination (including any annual bonus that may be due and payable to Mr. Fuller).
|
(iii) |
If upon or within six months subsequent to a change of control, Mr. Fuller’s employment is terminated by him for good reason or by the Company without cause, Mr. Fuller will be entitled to and be paid a termination payment (the “Change of Control Payment”) equal to one and one-half times the sum of (a) Mr. Fuller’s annual base salary at the time of such termination and (b) Mr. Fuller’s target annual bonus for the fiscal year in which his employment is terminated (as if the applicable performance criteria have been met at the level that would result in payment of the target annual bonus at the 100% level irrespective of whether or not that is the case); provided, however, that the Change of Control Payment will only be paid to Mr. Fuller if the change of control closes after the six month anniversary of the execution date of the Fuller Agreement and the change of control transaction meets a per share threshold price that is greater than or equal to $9.51 per share. In the event a change of control transaction closes in the first six months following the execution date of the Fuller Agreement, or closes pursuant to an agreement entered into in the first six months following the execution date of the Fuller Agreement, Mr. Fuller will not be entitled to the Change of Control Payment upon his termination.
|
(i) |
Upon termination of Ms. Beischel’s employment by Ms. Beischel for good reason or by the Company without cause (as each term is defined in the Beischel Agreement), Ms. Beischel will be entitled to a termination payment equal to one times the sum of (a) Ms. Beischel’s annual base salary at the time of such termination and (b) Ms. Beischel’s target annual bonus for the fiscal year in which her employment is terminated. The termination payment will be paid in a lump sum.
|
(ii) |
Upon termination of Ms. Beischel’s employment by the resignation of Ms. Beischel without good reason or by the Company with cause or by reason of death or disability or for any other reason except as provided in the immediately preceding paragraph above, Ms. Beischel will be due no further compensation other than what is due and owing through the effective date of Ms. Beischel’s resignation or termination (including any annual bonus that may be due and payable to Ms. Beischel).
|
(i) |
Upon termination of Mr. Salomon’s employment by Mr. Salomon for good reason or by the Company without cause (as each term is defined in the Fuller Agreement), Mr. Salomon will be entitled to a termination payment equal to one times the sum of (a) Mr. Salomon’s annual base salary at the time of such termination and (b) Mr. Salomon’s target annual bonus for the fiscal year in which his employment is terminated. The termination payment will be paid in a lump sum.
|
(ii) |
Upon termination of Mr. Salomon’s employment by the resignation of Mr. Salomon without good reason or by the Company with cause or by reason of death or disability or for any other reason except as provided in the immediately preceding paragraph above, Mr. Salomon will be due no further compensation other than what is due and owing through the effective date of Mr. Salomon’s resignation or termination (including any annual bonus that may be due and payable to Mr. Salomon).
|
· |
8x8 Inc
|
· |
Alaska Communications Sys Gp
|
· |
Atn International Inc
|
· |
Boingo Wireless Inc
|
· |
Brightcove Inc
|
· |
Cogent Communications Hldgs
|
· |
Demandware Inc
|
· |
Five9 Inc
|
· |
Fusion Telecommunications
|
· |
GTT Communications Inc
|
· |
Hawaiian Telcom Holdco Inc
|
· |
Incontact Inc
|
· |
Inteliquent Inc
|
· |
Iridium Communications Inc
|
· |
Limelight Networks Inc
|
· |
LivePerson Inc
|
· |
LogMeIn Inc
|
· |
Lumos Networks Corp
|
· |
Ooma Inc
|
· |
ORBCOMM Inc
|
· |
Shenandoah Telecommun Co
|
· |
Spok Holdings Inc
|
· |
Synacor Inc
|
Name
|
Fees
Earned or Paid in Cash ($) |
Stock
Awards ($) |
All Other
Compensation ($) |
Total
($) |
||||||||||||
Richard Harris(1)
|
102,000
|
60,000
|
-
|
162,000
|
||||||||||||
Donald A. Burns(2)
|
38,904
|
-
|
-
|
38,904
|
||||||||||||
Alan Howe(3)
|
71,096
|
60,000
|
-
|
131,096
|
||||||||||||
Tali Yaron-Eldar(4)
|
70,000
|
60,000
|
-
|
130,000
|
||||||||||||
Izhak Gross(5)
|
106,429
|
111,800
|
-
|
218,229
|
||||||||||||
Dr. Yuen Wah Sing(6)
|
50,000
|
60,000
|
-
|
110,000
|
(1) |
Mr. Harris served on the Audit Committee and Compensation Committee for all of fiscal year 2017. Additionally, Mr. Harris earned $32,000 serving on Special Committees during 2017. Mr. Harris had 8,108 unvested stock awards at December 31, 2017.
|
(2) |
Mr. Burns served as Chairman of the Board from January 1, 2013 until his resignation from the Board on May 22, 2017. As Chairman, Mr. Burns received $38,904 for his partial year of service during the year ended December 31, 2017. Mr. Burns had no outstanding stock awards or options awards at December 31, 2017.
|
(3) |
Mr. Howe was appointed to the Board of Directors on April 19, 2017, and served on the Audit and Nominating and Governance Committees. Mr. Howe also earned $22,000 during 2017 for his service on Special Committees. Mr. Howe had 8,108 unvested stock awards at December 31, 2017.
|
(4) |
Ms. Yaron-Eldar served on the Audit Committee and Compensation Committee for all of fiscal year 2017. Ms. Yaron-Eldar had 8,108 unvested stock awards at December 31, 2017.
|
(5) |
Mr. Gross was appointed to the Board of Directors on August 9, 2016 to fill a vacancy caused by a Board member’s retirement. He served on the Audit Committee and Compensation Committee from the date of his appointment until the appointment of Mr. Howe in April 2017. Upon the resignation of Mr. Burns, Mr. Gross was appointed chairman of the Board and he served as the Chairman for the remainder of 2017. Additionally, Mr. Gross earned $25,333 during 2017 for his service on Special Committees. Mr. Gross had 15,108 stock awards unvested at December 31, 2017.
|
(6) |
Dr. Sing had had 8,108 unvested stock awards at December 31, 2017.
|
· |
A fixed annual payment of $50,000 (to be paid quarterly) for service as a member of the Board, and $100,000 for the Chairman of the Board, plus, if applicable, a fixed annual payment of $10,000 (to be paid quarterly) for service as a member of each committee of the Board on which the director serves (the standing committees of our Board are the Audit Committee, Compensation Committee, and the Nomination and Governance Committee). Additionally, Board members received $10,000 for service on a “Special Committee” plus $1,000 per meeting for each meeting in excess of three meetings.
|
· |
Reimbursement of business expenses and travel and accommodation expenses incurred in the performance of duties as a member of the Board and/or any Board committee, including, for illustration purposes, business class flying tickets for overseas travels, suitable hotel accommodation, taxi and/or leased vehicles.
|
Ordinary Shares
Beneficially Owned |
||||||||
Name of Beneficial Owner
|
Number(1)
|
Percent
|
||||||
Adams Street Partners, LLC (2)
One North Wacker Drive, Suite 2200 Chicago, IL 60606 |
1,976,861
|
12.21
|
%
|
|||||
B. Riley FBR, Inc. (3)
11100 Santa Monica Boulevard, Suite 800 Los Angeles, CA 90025 |
1,249,600
|
7.72
|
%
|
|||||
Renaissance Technologies LLC (4)
800 Third Avenue New York, NY 10022 |
855,900
|
5.29
|
%
|
|||||
The Goldman Sachs Group, Inc. (5)
|
840,329
|
5.2
|
%
|
|||||
Don Carlos Bell III (6)
|
-
|
-
|
||||||
Izhak Gross
|
2,333
|
*
|
||||||
Richard Harris
|
13,046
|
*
|
||||||
Alan Howe
|
-
|
-
|
||||||
Dr. Yuen Wah Sing (7)
|
293,684
|
1.80
|
%
|
|||||
Gerald Vento (former executive officer) (8)
|
217,167
|
1.34
|
%
|
|||||
Tali Yaron-Eldar
|
17,000
|
*
|
||||||
Thomas Fuller (9)
|
-
|
-
|
||||||
Jose Gordo (former executive officer) (10)
|
301,844
|
1.85
|
%
|
|||||
Dvir Salomon (11)
|
83,334
|
*
|
||||||
Kristen Beischel (12)
|
-
|
-
|
||||||
Directors and current executive officers as a group (9 persons) (13)
|
409,397
|
2.51
|
%
|
* |
Represents less than 1% of the outstanding ordinary shares.
|
(1) |
Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to ordinary shares. Unless otherwise indicated below, to our knowledge, all persons included in this table have sole voting and investment power with respect to their ordinary shares, except to the extent authority is shared by spouses under applicable law. Pursuant to the rules of the SEC, the number of ordinary shares deemed outstanding includes shares issuable upon settlement of restricted ordinary shares held by the respective person or group that will vest within 60 days of November 30, 2017 and pursuant to ordinary share options held by the respective person or group that are currently exercisable or may be exercised within 60 days of the date hereof, which we refer to as presently exercisable ordinary share options.
|
(2) |
Information based on the Schedule 13G Amendment filed with the SEC on February 13, 2017 by Adams Street Partners, LLC.
|
(3) |
Information based on the Schedule 13G filed with the SEC on January 3, 2018 by B. Riley FBR, Inc.
|
(4) |
Information based on the Schedule 13G filed with the SEC on February 14, 2017 by Renaissance Technologies LLC (“RTC”) and Renaissance Technologies Holdings Corporation (“RTHC”). RTC and RTHC have sole voting power over 661,697 shares, sole dispositive power over 822,850 shares, and shared voting and dispositive power over 33,050 shares.
|
(5) |
Information based on the Schedule 13G filed with the SEC on January 26, 2018 by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC, each of whom report shared voting and shared dispositive power over all shares reported on the Schedule 13G.
|
(6) |
Mr. Bell was appointed President and Chief Executive Officer on March 9, 2017 and was elected to the Board by the shareholders on April 19, 2017. He currently owns no shares.
|
(7) |
Includes 100,000 shares subject to currently exercisable options with an exercise price of $19.23 per share.
|
(8) |
Mr. Vento served as President and Chief Executive Officer through the 2016 fiscal year and until March 9, 2017. He resigned from the Board on June 17, 2017 and is no longer with the Company.
|
(9) |
Mr. Fuller was appointed Executive Vice President and Chief Financial Officer effective May 11, 2017. He currently owns no shares.
|
(10) |
Mr. Gordo served as Chief Financial Officer through the 2016 fiscal year and until May 11, 2017. Mr. Gordo is no longer with the Company. Reported beneficial ownership includes 166,436 shares subject to currently exercisable options with an exercise price of $9.33 per share.
|
(11) |
Mr. Salomon was appointed Executive Vice President and Chief Technology Officer effective May 8, 2017. He currently owns 83,334 shares.
|
(12) |
Ms. Beischel was appointed Executive Vice President and Chief Marketing Officer effective May 8, 2017. She currently owns no shares.
|
(13) |
Includes 100,000 shares subject to currently exercisable options.
|
· |
the majority voted in favor includes a majority of the shares held by non-controlling shareholders who do not have a personal interest in the approval of Proposal 2 that are voted at the Meeting, excluding abstentions; or
|
· |
the total number of shares held by non-controlling, disinterested shareholders (as described in the previous bullet-point) that are voted against approval of Proposal 2 does not exceed two percent of the aggregate voting rights in the Company.
|
Page | ||
A-2
|
||
Section 1.01.
|
Definitions
|
A-2
|
Section 1.02.
|
Other Definitional and Interpretative Provisions
|
A-11
|
A-12
|
||
Section 2.01.
|
The Merger
|
A-12
|
Section 2.02.
|
Closing
|
A-12
|
Section 2.03.
|
Effective Time
|
A-12
|
Section 2.04.
|
Effects of the Merger
|
A-12
|
Section 2.05.
|
Memorandum and Articles of Association of the Surviving Corporation
|
A-13
|
Section 2.06.
|
Directors and Officers of the Surviving Corporation
|
A-13
|
Section 2.07.
|
Conversion of Company Stock
|
A-13
|
Section 2.08.
|
Disposition of Certificates and Book-Entry Shares
|
A-15
|
A-19
|
||
Section 3.01.
|
Organization, Standing and Corporate Power
|
A-19
|
Section 3.02.
|
Authority
|
A-19
|
Section 3.03.
|
Non-Contravention; Consents and Approvals
|
A-20
|
Section 3.04.
|
Capitalization
|
A-21
|
Section 3.05.
|
Subsidiaries
|
A-22
|
Section 3.06.
|
Company SEC Documents; Financial Statements
|
A-23
|
Section 3.07.
|
No Undisclosed Liabilities
|
A-25
|
Section 3.08.
|
Proxy Statement; Company Information
|
A-25
|
Section 3.09.
|
Absence of Certain Developments
|
A-25
|
Section 3.10.
|
Litigation
|
A-26
|
Section 3.11.
|
Compliance with Laws
|
A-26
|
Section 3.12.
|
Material Contracts
|
A-27
|
Section 3.13.
|
Taxes
|
A-29
|
Section 3.14.
|
Labor and Employment Matters
|
A-30
|
Section 3.15.
|
Employee Benefit Plans
|
A-31
|
Section 3.16.
|
Intellectual Property
|
A-32
|
Section 3.17.
|
Government Grants
|
A-35
|
Section 3.18.
|
Real Property
|
A-35
|
Section 3.19.
|
Environmental Matters
|
A-35
|
Section 3.20.
|
Customers and Suppliers
|
A-36
|
Section 3.21.
|
Insurance
|
A-36
|
Section 3.22.
|
Affiliate Transactions
|
A-36
|
Section 3.23.
|
Export Matters
|
A-37
|
Section 3.24.
|
Bribery; Anti-Money Laundering
|
A-37
|
Section 3.25.
|
Takeover Laws
|
A-37
|
Section 3.26.
|
Opinion of Financial Advisor
|
A-37
|
Section 3.27.
|
No Brokers
|
A-38
|
Section 3.28.
|
Indebtedness
|
A-38
|
Section 3.29.
|
Solvency Determination
|
A-38
|
Section 3.30.
|
Operating Performance
|
A-38
|
Section 3.31.
|
No Other Representations or Warranties
|
A-38
|
A-39
|
||
Section 4.01.
|
Organization, Standing and Corporate Power
|
A-39
|
Section 4.02.
|
Authority
|
A-39
|
Section 4.03.
|
Non-Contravention; Consents and Approvals
|
A-39
|
Section 4.04.
|
Ownership and Operations of Merger Sub
|
A-40
|
Section 4.05.
|
Information in the Proxy Statement
|
A-40
|
Section 4.06.
|
Litigation
|
A-41
|
Section 4.07.
|
Financing
|
A-41
|
Section 4.08.
|
Ownership of Company Stock
|
A-41
|
Section 4.09.
|
No Brokers
|
A-41
|
Section 4.10.
|
Shareholder and Management Arrangements
|
A-41
|
Section 4.11.
|
Solvency Determination
|
A-42
|
Section 4.12.
|
Parent and Merger Sub Board Approval
|
A-42
|
Section 4.13.
|
No Other Representations or Warranties; Independent Investigation
|
A-42
|
A-43
|
||
Section 5.01.
|
Conduct of Business of the Company
|
A-43
|
Section 5.02.
|
Acquisition Proposals
|
A-46
|
Section 5.03.
|
Preparation of Proxy Statement; Shareholders Meeting
|
A-49
|
Section 5.04.
|
Access to Information; Confidentiality
|
A-51
|
Section 5.05.
|
Reasonable Best Efforts.
|
A-51
|
Section 5.06.
|
Indemnification, Exculpation and Insurance.
|
A-56
|
Section 5.07.
|
Public Announcements
|
A-58
|
Section 5.08.
|
Section 16 Matters
|
A-58
|
Section 5.09.
|
Stock Exchange Delisting
|
A-58
|
Section 5.10.
|
Takeover Laws
|
A-58
|
Section 5.11.
|
Shareholder Litigation
|
A-58
|
Section 5.12.
|
Merger Proposal; Certificate of Merger.
|
A-59
|
Section 5.13.
|
Status; Notifications
|
A-60
|
Section 5.14.
|
Financing Cooperation
|
A-60
|
Section 5.15.
|
IIA Notice
|
A-61
|
Section 5.16.
|
Intellectual Property Assignments
|
A-61
|
A-62
|
||
Section 6.01.
|
Conditions to the Obligations of Each Party to Effect the Merger
|
A-62
|
Section 6.02.
|
Conditions to the Obligations of Parent and Merger Sub to Effect the Merger
|
A-62
|
Section 6.03.
|
Conditions to the Obligations of the Company to Effect the Merger
|
A-64
|
A-65
|
||
Section 7.01.
|
Termination
|
A-65
|
Section 7.02.
|
Effect of Termination
|
A-67
|
Section 7.03.
|
Fees and Expenses
|
A-67
|
Section 7.04.
|
Amendment
|
A-69
|
Section 7.05.
|
Extension; Waiver
|
A-69
|
A-69
|
||
Section 8.01.
|
No Survival
|
A-69
|
Section 8.02.
|
Notices
|
A-70
|
Section 8.03.
|
Entire Agreement
|
A-71
|
Section 8.04.
|
Disclosure Schedule
|
A-71
|
Section 8.05.
|
Binding Effect; Assignment
|
A-72
|
Section 8.06.
|
Guaranty of Obligations
|
A-72
|
Section 8.07.
|
No Third Party Beneficiaries
|
A-73
|
Section 8.08.
|
Governing Law
|
A-73
|
Section 8.09.
|
Consent to Jurisdiction
|
A-73
|
Section 8.10.
|
Waiver of Jury Trial
|
A-73
|
Section 8.11.
|
Specific Performance
|
A-74
|
Section 8.12.
|
Severability
|
A-74
|
Section 8.13.
|
Counterparts
|
A-74
|
Exhibit A
|
Articles of the Surviving Corporation
|
A-76 |
Defined Term
|
Section
|
Acceptable Confidentiality Agreement
|
Section 5.02(a)
|
Acquisition Proposal
|
Section 5.02(g)(i)
|
Action
|
Section 1.01
|
Affiliate
|
Section 1.01
|
Agreement
|
Preamble
|
Alternative Acquisition Agreement
|
Section 5.02(c)
|
Anti-Corruption Laws
|
Section 1.01
|
Anti-Money Laundering Laws
|
Section 1.01
|
Antitrust Laws
|
Section 1.01
|
Assignment Period
|
Section 8.05
|
Bankruptcy and Equity Exceptions
|
Section 3.02(a)
|
Benefit Plan
|
Section 1.01
|
BofA Merrill Lynch
|
Section 3.26
|
Book-Entry Shares
|
Section 2.07(c)
|
Defined Term
|
Section
|
Burdensome Condition
|
Section 5.05(e)
|
Business Day
|
Section 1.01
|
Certificate
|
Section 2.07(c)
|
Certificate of Merger
|
Section 2.03
|
Closing
|
Section 2.02
|
Closing Date
|
Section 2.02
|
Code
|
Section 1.01
|
Committee
|
Recitals
|
Communications Act
|
Section 1.01
|
Companies Registrar
|
Section 2.03
|
Company
|
Preamble
|
Company Adverse Recommendation Change
|
Section 5.02(c)
|
Company Balance Sheet
|
Section 1.01
|
Company Board Recommendation
|
Section 3.02(b)
|
Company Stock
|
Section 1.01
|
Company Equity Awards
|
Section 2.07(d)(iii)
|
Company Equity Plan
|
Section 1.01
|
Company Intellectual Property
|
Section 1.01
|
Company IT Assets
|
Section 1.01
|
Company SEC Documents
|
Section 3.06(a)
|
Company Stock
|
Section 1.01
|
Company Stock Option
|
Section 2.07(d)(i)
|
Company Shareholder Approval
|
Section 3.02(a)
|
Company Termination Fee
|
Section 1.01
|
Confidential Information
|
Section 3.16(f)
|
Confidentiality Agreement
|
Section 5.04
|
Contract
|
Section 1.01
|
D&O Insurance
|
Section 5.06(c)
|
Delaware Courts
|
Section 8.09
|
Disclosure Schedule
|
Article 3
|
Effective Time
|
Section 2.03
|
End Date
|
Section 7.01(b)(i)
|
Environmental Laws
|
Section 1.01
|
ERISA
|
Section 1.01
|
Exchange Act
|
Section 1.01
|
Excluded Shares
|
Section 2.07(b)
|
Export and Sanctions Regulations
|
Section 3.23
|
FCC
|
Section 1.01
|
FTC
|
Section 1.01
|
GAAP
|
Section 1.01
|
Government Grant
|
Section 1.01
|
Governmental Authority
|
Section 1.01
|
HSR Act
|
Section 1.01
|
ICL
|
Section 2.01
|
IIA
|
Section 1.01
|
Defined Term
|
Section
|
IIA Notice
|
Section 1.01
|
Indebtedness
|
Section 1.01
|
Indemnification Agreements
|
Section 5.06(a)
|
Indemnified Parties
|
Section 5.06(a)
|
Information Agent
|
Section 2.08(h)(ii)
|
Intellectual Property
|
Section 1.01
|
Interim Option Tax Ruling
|
Section 5.05(h)
|
Intervening Event
|
Section 1.01
|
Israeli Employees
|
Section 3.14(b)
|
ITA
|
Section 2.08(h)(i)
|
Knowledge of the Company
|
Section 1.01
|
Law
|
Section 1.01
|
Leased Real Property
|
Section 1.01
|
Lien
|
Section 1.01
|
Material Adverse Effect
|
Section 1.01
|
Material Contract
|
Section 3.12(a)
|
Material Customer
|
Section 3.20
|
Material Supplier
|
Section 3.20
|
Merger
|
Section 2.01
|
Merger Notice
|
Section 1.01
|
Merger Proposal
|
Section 5.12(a)
|
Merger Sub
|
Preamble
|
Non-Owned Intellectual Property
|
Section 1.01
|
Notice of Superior Proposal / Intervening Event
|
Section 5.02(c)
|
Open Source License
|
Section 3.16(h)
|
Option Payments
|
Section 2.07(d)(i)
|
Option Tax Ruling
|
Section 5.05(h)
|
Order
|
Section 1.01
|
Ordinance
|
Section 1.01
|
Organizational Documents
|
Section 1.01
|
Owned Intellectual Property
|
Section 1.01
|
Parent
|
Preamble
|
Parties
|
Preamble
|
Paying Agent
|
Section 2.08(a)
|
Paying Agent Agreement
|
Section 2.08(a)
|
Payment Fund
|
Section 2.08(a)
|
Payor
|
Section 2.08(h)(i)
|
Per Share Merger Consideration
|
Section 2.07(c)
|
Permits
|
Section 3.11(a)(ii)
|
Permitted Assignment
|
Section 8.05
|
Permitted Liens
|
Section 1.01
|
Person
|
Section 1.01
|
Premium Cap
|
Section 5.06(c)
|
Proposed Assignee
|
Section 8.05
|
Proxy Statement
|
Section 3.08
|
Defined Term
|
Section |
Real Property Leases
|
Section 1.01
|
Representatives
|
Section 1.01
|
Restricted Share Payments
|
Section 2.07(d)(ii)
|
Restricted Shares
|
Section 2.07(d)(ii)
|
Sarbanes-Oxley Act
|
Section 1.01
|
SEC
|
Section 1.01
|
Securities Act
|
Section 1.01
|
Specified Date
|
Section 3.04(a)
|
Shareholders Meeting
|
Section 5.03(c)
|
Software
|
Section 1.01
|
State Regulators
|
Section 1.01
|
Subsidiary
|
Section 1.01
|
Superior Proposal
|
Section 5.02(g)(ii)
|
Surviving Corporation
|
Section 2.01
|
Takeover Laws
|
Section 1.01
|
Tax Declaration
|
Section 2.08(c)
|
Tax Return
|
Section 1.01
|
Taxes
|
Section 1.01
|
Taxing Authority
|
Section 1.01
|
Valid Certificate
|
Section 2.08(h)(i)
|
Withholding Tax Ruling
|
Section 5.05(i)
|
|
B. RILEY FINANCIAL, INC.
By: /s/ Bryant Riley
Name: Bryant Riley
Title: Chairman & CEO
B. R. ACQUISITION LTD.
By: /s/ Kenneth M. Young
Name: Kenneth M. Young
Title: CEO
MAGICJACK VOCALTEC LTD.
By: /s/ Don Carlos Bell, III
Name: Don Carlos Bell, III
Title: Chief Executive Officer
|
6.1 |
Public Offering – The Company shall not offer to the public any securities or debentures.
|
6.2 |
The Number of Company Shareholders – The number of shareholders in the Company shall not exceed 50 shareholders, excluding Company employees and former Company’s employees that were issued shares during their employment and continue to hold shares after their employment has terminated. Two or more persons which jointly hold one or more shares of the Company shall be deemed as a single shareholder.
|
6.3 |
Redeemable Securities – The Company’s board of directors, in its discretion, may issue redeemable securities, bearing such rights and subject to such conditions, as determined by the board of directors.
|
6.4 |
Forfeiture – The board of directors of the Company may cause the forfeiture of a share issued by the Company if the consideration for such share was not received, in part or in whole, in accordance with the terms of the issuance of such share.
|
9.1 |
The Company may choose not to convene an annual meeting, unless such a meeting is required in order to appoint an auditor.
|
9.2 |
The Company is not required to attach financial statements to a notice of its annual meeting. However, the Company shall make its financial statements available at its registered office during normal working hours, or at another time or location if so noted in the notice of its annual meeting.
|
9.3 |
The general meeting may assume the authority of another organ as well as to assign authorities of the chief executive officer to the board of directors for the purpose of a certain matter or period of time.
|
9.4 |
If there is no quorum for a general meeting, such meeting shall be postponed by one business day.
|
9.5 |
Any resolution adopted in writing, signed by all of the shareholders of the Company at the date of the resolution, shall be deemed to be in full force for any matter or purpose, and shall be considered as a resolution adopted by the general meeting of the Company which has been invited and convened properly for the purpose of such decision.
|
10. |
Board of Directors
|
10.1 |
The number of the Company directors shall not be less than one (1), and not more than five (5), unless otherwise resolved by the general meeting. If the board of directors has only one director, the provisions of these Articles of Association that relate to a board of directors with two directors or more shall be deemed amended accordingly.
|
10.2 |
Appointment of directors – The Company’s directors shall be appointed by a resolution of the general meeting.
|
10.3 |
Validity of appointment – The appointed directors shall assume their position as aforesaid in Section 10.2, as applicable, unless a later date shall be determined by the resolution.
|
10.4 |
Alternate Director – A director may, from time to time appoint himself an alternate director, dismiss this alternate director, and appoint a new alternate director in the place of an alternate director who has stepped down from his position for any reason, whether for a certain meeting or on a permanent basis. A director may appoint as an alternate director a person which currently serves as a director or as an alternate director.
|
10.5 |
Any resolution adopted in writing, signed by all of the Company’s directors at the date of the resolution, which are entitled to participate and vote with respect to the subject matter of the resolution, shall be deemed to be in full force for any matter or purpose, and shall be considered as a resolution adopted by a meeting of the board of directors which was convened properly for the purpose of such decision.
|
12.1 |
In accordance with the provisions of the Companies Law, the general meeting may appoint an auditor for a period exceeding one year, as determined by the general meeting.
|
12.2 |
The board of directors shall determine the salary of the Company’s auditor for its activities related to the audit of the Company as well as the salary for other services which are non-audit services, unless otherwise determined by the general meeting of the Company.
|
13. |
Insurance
|
13.1 |
a breach of duty of care to the Company or to any other person;
|
13.2 |
a breach of the duty of loyalty to the Company, provided that the office holder acted in good faith and had reasonable grounds to assume that the act that resulted in such breach would not harm the interests of the Company;
|
13.3 |
a financial liability imposed on such office holder in favor of any other person; and
|
13.4 |
any other liability insurable under the Companies Law.
|
14. |
Indemnity
|
14.1 |
Subject to the provisions of the Companies Law including the receipt of all approvals as required therein or under any applicable law, the Company may resolve retroactively to indemnify an office holder of the Company with respect to the following liabilities and expenses, provided that such liabilities or expenses were incurred by such office holder in such office holder’s capacity as an office holder of the Company:
|
14.1.1 |
a financial liability imposed on an office holder in favor of another person by any judgment, including a judgment given as a result of a settlement or an arbitrator’s award which has been confirmed by a court in respect of an act performed by the office holder.
|
14.1.2 |
reasonable litigation expenses, including attorneys’ fees, expended by the office holder as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (i) no indictment (as defined in the Companies Law) was filed against such office holder as a result of such investigation or proceeding; and (ii) no financial liability as a substitute for the criminal proceeding (as defined in the Companies Law) was imposed upon him or her as a result of such investigation or proceeding or if such financial liability was imposed, it was imposed with respect to an offence that does not require proof of criminal intent.
|
14.1.3 |
reasonable litigation costs, including attorney’s fees, expended by an office holder or which were imposed on an office holder by a court in proceedings filed against the office holder by the Company or in its name or by any other person or in a criminal charge in respect of which the office holder was acquitted or in a criminal charge in respect of which the office holder was convicted for an offence which did not require proof of criminal intent.
|
14.1.4 |
Any other liability indemnifiable under the Companies Law.
|
14.2 |
Subject to the provisions of the Companies Law including the receipt of all approvals as required therein or under any applicable law, the Company may undertake in advance to indemnify an office holder of the Company with respect to those liabilities and expenses described in the following Articles:
|
14.2.1 |
Sub-Article 14.1.2 and 14.1.3; and
|
14.2.2 |
Sub-Article 14.1.1, provided that the undertaking to indemnify:
|
14.2.2.1 |
is limited to such events which the directors shall deem to be likely to occur in light of the operations of the Company at the time that the undertaking to indemnify is made and for such amounts or criteria which the directors may, at the time of the giving of such undertaking to indemnify, deem to be reasonable under the circumstances; and
|
14.2.2.2 |
the undertaking to provide such indemnification shall set forth such events which the directors shall deem to be likely to occur in light of the operations of the Company at the time that the undertaking to indemnify is made, and the amounts and/or criteria which the directors may, at the time of the giving of such undertaking to indemnify, deem to be reasonable under the circumstances.
|
15. |
Exemption
|
16. |
Exemption, Indemnification and Insurance – General
|
16.1 |
The aforesaid provisions regarding exemption, indemnification and insurance, are not intended and shall not restrict the Company in any way in engaging in an agreement with respect to exemption, insurance or indemnification in the following matters:
|
16.1.1 |
Any person which is not an officer of the Company, including employees, service providers or consultants of the Company, which are not officers of the Company.
|
16.1.2 |
Officers of other companies. The Company may engage in a contract regarding exemption, indemnification and insurance of officers in companies controlled by the Company, related to the Company or other companies in which the Company has interest in, to the maximum extent permitted by any law, and the provisions above regarding exemption, indemnification and insurance of office holders of the Company shall apply, with applicable changes.
|
16.2 |
It is hereby clarified that in this Section, an obligation regarding exemption, indemnification and insurance of office holders of the Company may remain in force even after the applicable officer ceases to serve in the Company.
|
Merrill Lynch, Pierce, Fenner & Smith Incorporated
|
GLOBAL CORPORATE & INVESTMENT BANKING |
(1) |
reviewed certain publicly available business and financial information relating to magicJack;
|
(2) |
reviewed certain internal financial and operating information with respect to the business, operations and prospects of magicJack furnished to or discussed with us by the management of magicJack, including certain financial forecasts relating to magicJack (including financial forecasts relating to magicJack’s Spark initiative) prepared by the management of magicJack (such forecasts, “magicJack Forecasts”), and have discussed with the management of magicJack its assessment of the probability of success of magicJack’s Spark initiative reflected in the magicJack Forecasts;
|
(3) |
discussed the past and current business, operations, financial condition and prospects of magicJack with members of senior management of magicJack;
|
(4) |
reviewed the trading history for magicJack Stock and a comparison of that trading history with the trading histories of other companies we deemed relevant;
|
(5) |
compared certain financial and stock market information of magicJack with similar information of other companies we deemed relevant;
|
(6) |
compared certain financial terms of the Merger to financial terms, to the extent publicly available, of other transactions we deemed relevant;
|
(7) |
considered the fact that magicJack publicly announced that it would explore its strategic alternatives and the results of our efforts on behalf of magicJack to solicit, at the direction of magicJack, indications of interest and definitive proposals from third parties with respect to a possible acquisition of magicJack;
|
(8) |
reviewed a draft, dated November 8, 2017, of the Agreement (the “Draft Agreement”); and
|
(9) |
performed such other analyses and studies and considered such other information and factors as we deemed appropriate.
|
Please mark vote
as indicated in
this example
|
☒
|
EXTRAORDINARY GENERAL MEETING OF THE SHAREHOLDERS
OF MAGICJACK VOCALTEC LTD. |
|
March 19, 2018
|
1.
|
To approve the Agreement and Plan of Merger by and among the Company, B. Riley Financial, Inc., and B.R. Acquisition Ltd., and the terms of the merger contemplated thereby.
|
FOR
☐
|
AGAINST
☐
|
ABSTAIN
☐
|
Confirm that you are not Parent, Merger Sub, any person holding at least 25% of the means of control of either of them, anyone acting on their behalf, or any relative or corporation controlled by, any of the foregoing (If you do not respond, your vote on this Proposal will not be counted)
|
CONFIRM
☐
|
|||
2.
|
To approve an amendment to the Employment Agreement and an amendment to the Restricted Stock Agreement with Don Carlos Bell III, the Company’s Chief Executive Officer, related to the transactions contemplated by the Merger Agreement.
|
FOR
☐
|
AGAINST
☐
|
ABSTAIN
☐
|
Confirm that you are not a controlling shareholder and do not have a Personal Interest in the approval of Proposal 2 (If you do not respond, you will be considered as having a Personal Interest in this Proposal and your vote will not be counted) | CONFIRM
☐
|
|||
3.
|
To approve, on a non-binding, advisory basis, certain compensation that will be paid or may become payable to our named executive officers in connection with the Merger.
|
FOR
☐
|
AGAINST
☐
|
ABSTAIN
☐
|
Signature___________________________________________
|
Signature __________________________________________
|
(Joint Owner)
|
|
Date _______________________
|
Date _______________________
|
NOTE: |
Please sign exactly as your name appears on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|